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General practice is the jazz of medicine,  
the general practitioner is the bohemian among doctors, 
states Marshall Marinker. 
Approved – souls and blues are valuable parts 
 of general practice – but so must be: research, 
 construction of our scientific foundation  
and self-critical appraisal. 
Per Fugelli 
Abstract 
Background: Depression is a major source of human suffering and a growing 
challenge for societies worldwide. The lion’s share of depressed persons in 
Sweden are diagnosed and treated in primary care. There is an urgent need for 
new ways of treating and cooperating within and between care levels. Internet-
mediated cognitive behavioural therapy (ICBT) and collaborative care with a 
care manager (CCCM) are two examples of implementations intended to meet 
the demands of reinforced continuity, accessibility and coordination in 
treatment and care of patients with mild to moderate depression. 
Aim: The aim of this thesis was to evaluate ICBT and CCCM in the Swedish 
primary care setting from the perspectives of cost-effectiveness and feasibility 
including the experience of patients and staff. 
Papers I–II: ICBT was compared to treatment as usual (TAU) in a cost-
effectiveness analysis made from both health care and societal perspectives. 
The patient experience of ICBT was studied by means of focus groups and 
interviews. ICBT seemed to be an alternative as effective and cost-effective as 
TAU from both from health-care and societal perspectives. The largest cost in 
both groups was productivity loss related to sick leave. ICBT was shown to be 
an attractive treatment for some patients, but not for all. The freedom of ICBT 
was appreciated but the responsibility placed on the patient was considerable. 
Papers III–IV: CCCM was compared to care as usual (CAU) in a cost-
effectiveness analysis from both health-care and societal perspectives. 
Questionnaires including closed and open questions were used to study the 
experiences of primary care centre (PCC) directors and clinicians. CCCM was 
shown to be cost-effective compared to CAU from both health-care and 
societal perspectives. CCCM was also perceived to be effective and positive 
by both directors and clinicians. Facilitators for CCCM were support from 
colleagues and directors, cooperative skills and positive attitudes of care 
managers and clinicians. Barriers were high workload, shortage of staff and 
extensive requirements and demands from health-care management. 
Conclusion: ICBT seems to be an acceptable alternative to TAU in terms of 
patient experience and cost-effectiveness. CCCM is highly cost-effective 
compared to CAU and both PCC clinicians and directors are generally positive 
to implementing – and working within – CCCM.  
Keywords: primary care, cost-effectiveness, depression, ICBT, care manager, collaborative 
care, effectiveness, organisation, continuity, accessibility, coordination, Sweden 
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Sammanfattning på svenska 
Depression är en stor källa till mänskligt lidande och över hela världen en 
växande utmaning för samhället. Människor med depression i Sverige söker 
hjälp, diagnostiseras och behandlas oftast i primärvården. I primärvård och 
allmänmedicin är kontinuitet, tillgänglighet och samordning ledstjärnor och vi 
vet att vårdkvaliteten ökar vid samtidig hög kontinuitet och tillgänglighet. 
Behovet av nya behandlingsmetoder och organisationsformer som stärker 
samarbete inom och mellan vårdnivåer för att uppnå bästa möjliga resultat vid 
behandling av depression, är stort. Internetmedierad kognitiv beteendeterapi 
(ICBT) och vårdsamordnare för psykisk ohälsa (CCCM) är två exempel på 
implementeringar som syftar till att stärka kontinuitet, tillgänglighet och 
samordning.  
Syftet med denna avhandling var att utvärdera ICBT och CCCM som 
behandling vid depression i den svenska primärvården ur perspektiven 
kostnadseffektivitet och genomförbarhet. För att bedöma en behandlings 
genomförbarhet är patienters och personals upplevelser och erfarenheter 
viktiga. 
Studie I–II: ICBT verkade vara effektiv och kostnadseffektiv i samma 
utsträckning som sedvanlig behandling både ur sjukvårds- och 
samhällsperspektiv. Den största kostnaden för både ICBT och sedvanlig 
behandling var relaterad till arbetsoförmåga och sjukskrivning. ICBT visade 
sig vara en attraktiv behandling för vissa patienter, men inte för alla. Friheten 
i ICBT var uppskattad men patientens ansvar för att behandlingen fortskred 
upplevdes som tungt.  
Studie III–IV: CCCM visade sig vara höggradigt kostnadseffektiv jämfört med 
sedvanlig primärvård både ur sjukvårds och samhällsperspektiv. CCCM 
uppfattades som effektiv och positiv av vårdcentralspersonal och deras chefer. 
Stöd från kollegor, samarbetsförmåga och positiva attityder hos personal och 
vårdsamordnare verkade underlätta arbetet inom CCCM. Hög 
arbetsbelastning, personalbrist och omfattande och parallella krav uppifrån i 
organisationen upplevdes som hindrande faktorer. 
ICBT verkar alltså vara ett acceptabelt alternativ till sedvanlig primärvård både 
vad gäller patientupplevelse och kostnadseffektivitet. Att ha flera goda 
behandlingsalternativ att välja mellan ligger helt i linje med de 
allmänmedicinska personcentrerade arbetsformerna. CCCM är mycket 
kostnadseffektivt jämfört med sedvanlig primärvård och både personal och 
chefer på vårdcentralerna är generellt positiva till CCCM. 
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Introduction 
A modern globalised world demands accessible, qualitative and coordinated 
health care. Achieving the best possible health and lowest possible morbidity 
for individuals is a major challenge for health care and society with limited 
resources. There is an urgent need for refined or new perspectives and working 
methods to be able to deal with this complex task. Health care needs to respond 
better – and faster – to the challenges of a changing world. There are major 
knowledge gaps regarding the care and treatment of fragile individuals and of 
chronic and multiple illnesses. This calls for the rapid development of 
knowledge in the areas of collaboration and coordination within health care. 
Research that goes beyond care levels and health care organisations should be 
based on primary care, which is the central node of the health care system. 
Primary care is the arena best suited to meet demands and lead development 
towards a modern and sustainable health care system. My research has been 
performed in this context. In this thesis I intend to present studies of examples 
of refined and new working methods from the real world of primary care. 
Many decisions will need to be taken and many priorities selected. These 
should – as all decision making in health care – lean on the principles of justice, 
equality, cost-effectiveness, need and solidarity. Health care must not harm. 
Results from applicable high quality research should form the knowledge basis 
of decision-making. Such research should be performed upstream of – or at 
least in line with – decisions. Such research should be designed for 
effectiveness and consider clinical effects but also the important aspects of 
feasibility, cost-effectiveness and patient and staff experiences and 
preferences. The effectiveness approach has a high probability of creating 
value in the real world. In this thesis I intend to present examples of 
effectiveness studies. 
 
Primary care 
Primary care as the core of health care systems  
Primary care is defined by the World Health Organisation (WHO) as a key 
process in any health care system. In 1978, at the Alma Ata WHO conference, 
all countries were encouraged to invest in primary care, with the ultimate goal 
of ‘better health for all’ (1). Primary care plays a central role in most health 
care systems world-wide, and strengthening primary care is widely seen as 
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central to enhancing equity and efficiency in health care (2). There is also 
considerable evidence that primary care systems contribute to overall health 
system performance and health. Primary care has been described as complex 
and multidimensional (3).  
Primary care should be the first contact, accessible at the time of need. It 
should be continuous meaning that it focuses on the long-term health of a 
person rather than the short duration of a disease. It should be comprehensive 
meaning that it offers a broad range of services appropriate to the common 
problems of the respective population and meets the needs of all ages and 
individuals. This includes initial medical assessments, treatment and follow-
up of illness and injuries that do not require hospitalisation, preventive 
measures, health promotion, rehabilitation, and death with dignity. Primary 
care should be coordinative in that it involves other specialists and social 
agents that the patient may need. Thus, primary care should be more than just 
a level of care or a gate-keeping function (2-5).  
 
Primary care is person-centred care  
Patient-centred care was mentioned already in the 60s by Mr and Mrs Balint 
(6) as a contradiction to the predominantly paternalistic model of the time, and 
was later described by Ian McWhinney as care in which ‘the physician tries to 
enter the patient's world, to see the illness through the patient's eyesʼ (7). It has 
also been defined as ‘care that is respectful of and responsive to individual 
patient preferences, needs, and values, and ensuring that patient values guide 
all clinical decisions’ (8). In recent years – aiming to encompass the entirety 
of a person's needs and preferences and not just the clinical or medical – there 
has been a move toward using the term person‐centred, rather than patient‐
centred. A recent definition of person-centred care is ‘care where individuals’ 
values and preferences are elicited and, once expressed, guide all aspects of 
their health care, supporting their realistic health and life goals. Person‐centred 
care is achieved through a dynamic relationship among individuals, others who 
are important to them, and all relevant providers. This collaboration informs 
decision‐making to the extent that the individual desires.’ (9).  
Primary care and general practice has a long and strong tradition of person-
centred care. The open-ended commitment of the general practitioner (GP) is 
to the person, not to ‘the person with a certain disease’. The care is 
comprehensive in its response to the needs of the people and reasonably 
accessible in their neighbourhood. (10). The relationship between the patient 
and the GP has been the subject of many attempts to describe and define. One 
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model developed in the 1990s is characterized by sustained partnership. Some 
of the defining features of this model are:  
 A focus on the whole person (i.e. the doctor attends to all 
health-related problems, either directly or through 
collaboration, regardless of the nature, origin, or organ system 
affected)  
 The doctor's knowledge of the patient (i.e. the doctor knows 
not just the patient's medical history but his or her personal 
history, family, work, community and cultural context, as 
well as his or her preferences, values, beliefs and ideals about 
health care, including preferences for information and 
participation in clinical decision making)  
 The choice of appropriately adapted care (i.e. the doctor 
tailors treatment recommendations to reflect the patient's 
goals and expectations regarding health and health care as 
well as the patient's beliefs, values and life circumstances)  
 The patient's participation in decision making (i.e. the doctor 
encourages the patient to participate in all aspects of care, and 
treatment and referrals are agreed to by both the clinician and 
the patient. To the extent that the patient wishes, the clinician 
informs the patient about diagnosis, prognosis and treatment 
options and includes the patient in treatment decisions) (11).  
In modern primary care, where close collaboration among care and patient is 
standard, this model is equally applicable.  
While secondary care mainly treats different patients with similar diseases, 
primary care treats the same patients and their different conditions and diseases 
for long periods. It might be challenging for secondary care to adapt to the 
model of person-centred care. However, in primary care, person-centeredness 
has been the guiding principle for decades, and today most medical schools 
educate and supervise consultation skills that facilitate patient-doctor 
communication and make person-centred care possible and actual (12). 
 
Historical perspective of primary care and general practice in Sweden  
A governmental organisation of district medical officers was established in the 
seventeenth century and tasked with mediating medical care and monitoring 
the health and sanitary conditions of the population (13). The first district 
medical officer of Gothenburg was the Dutch Pieter á Naaldwyck, who entered 
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his service of the Gothenburg population at the time of the city’s founding 1621 
(14). By the year 1900, the majority of the Swedish medical profession 
consisted of district medical officers (responsible for one geographical district 
each) in private practice – there were few hospital doctors. Primary care was 
thus completely dominant. The work of the district medical officer was 
exhausting and isolated as he (there were only males until Marianne Lindstén 
became the first female district medical officer in Vilhelmina in 1946) was on 
call twenty-four hours a day seven days a week. The only requirement to be 
employed as a district medical officer after graduation from medical school 
was eight months of service at a hospital (15). 
The first Swedish primary care centre (PCC) was established in Dalby, in the 
county of Skåne in 1968 (and was initially attached to the academy with a 
research commission). In the 1970s, PCCs were established throughout the 
country, and the organisational residence of primary care moved from national 
jurisdiction to the county councils. The requirements to be a GP (previously 
named district medical officer) were extended to three years at various hospital 
clinics. The PCCs typically employed GPs, nurses, physiotherapists and 
occupational therapists, and child and maternity care was integrated into the 
primary care organisations. Today these PCCs, with some extensions to the 
competence profile of the staff, are the predominant organisational form of the 
comprehensive primary care sector. 
General practice became a specialty in 1981, requiring four and a half years of 
practice in different specialities including two years in general practice. In 
1981 the first professorship in general practice was instituted at the Lund 
University in Skåne, and today research on general practice is conducted at all 
Swedish medical faculties. General practice is included in the basic education 
of all physicians and constitutes around a quarter of their internship 
(allmäntjänstgöring (AT)). The specialty of general practice today demands 
five years of internship (specialiseringstjänstgöring (ST)) following a 
comprehensive curriculum (16). An increasing number of GPs have been 
trained over the years – yet GP job vacancies prevail. One explanation could 
be the heavy workload and stressful working conditions of GPs. In a 
Commonwealth Fund survey of primary care physicians in several countries in 
2015, 56% of Swedish GPs reported their work as very or extremely stressful, 
which was the second highest proportion among all countries surveyed, and 
more than double the proportion of several countries (17).  
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Primary care in the Swedish health care system– organisation, 
economics and ethical principles 
In Sweden, the government is responsible for ensuring the health of all citizens 
according to the ethical principles stated in the Health Care Act (Hälso- och 
sjukvårdslagen) (18). Prioritization in health care should be based on the 
following principles: 
 The principle of human dignity: The entire population should 
be given health care on equal terms regardless of functions in 
society or personal characteristics. 
 The principle of need and solidarity: Those most in need of 
health care should be given priority. 
 The principle of cost-effectiveness: Health care should be 
conducted cost-effectively. However, considerations in the 
individual case should only be made in compliance with the 
above-mentioned principles (18-20). 
A national health care guarantee stipulates the patient’s right to get in touch 
with health care in zero days, and to see a GP within seven days (21). Since 
2010 the patient has the right to choose a primary care provider according to 
the Act on System of Choice in the Public Sector (Lagen om valfrihetssystem, 
(LOV)) (22). The health-care guarantee and choice of care together make it 
difficult to achieve the principles of equal care for everyone and priority for 
those most in need. The reforms have entailed improved contact opportunities 
with health-care services and more PCCs. However, this has mainly benefited 
patients of higher socio-economic status and with less care needs (20). 
Health care expenditure is mainly tax funded (80%). Sweden had the highest 
health-care spending in the European Union in 2015: 11% of gross domestic 
product (bruttonationalprodukten (BNP)) compared to the EU average of 9.9% 
(23). However, accessibility, waiting times and person-centred care 
coordination across care providers are enduring issues. Sweden has a large 
number of doctors and nurses: 4.2 practicing doctors per 1,000 persons, 
compared to the EU average of 3.6, but only 15% of the doctors are GPs which 
is considerably lower than most EU countries (23). The difficulty of recruiting 
GPs is a national problem particularly in rural areas, and this has led to a 
growing market for locum physicians employed by staffing companies which 
in turn has had a negative impact on both staff costs and continuity of care for 
patients. There has been a long-term shift from inpatient to outpatient care in 
Sweden. For example, the number of hospital beds has gradually become fewer 
and is now the lowest in EU with 2.3 beds per 1,000 persons of the general 
population compared to the EU average of 4.2. Hospital admission rates for 
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chronic diseases are also below the EU average. Yet, primary care has not been 
bolstered to respond to the increased need for outpatient care to the same extent 
(23). 
The funding and organisation of health care in Sweden lies largely (84%) on 
the twenty-one county councils/regions. The county councils are responsible 
for providing primary care to all county residents, and define the requirements 
to be met for primary care providers by means of regulations and 
reimbursement systems. The prerequisites to establish and run a PCC are the 
same whether it is funded privately or publicly. 
The PCCs of Sweden typically employ many professional categories. In 
addition to an average of four to five GPs, the teams consist of nurses 
specialised in general practice/diabetes/asthma, assistant nurses, 
psychotherapists, physiotherapists, occupational therapists and rehabilitation 
coordinators. The teams cooperate to give care to – and to work preventively 
with – the patients. This includes maternity and child care. The PCC is also the 
health care instance with the greatest responsibility for coordinating care with 
a patient’s additional carers. The PCCs cooperate closely with the local 
municipality in elder care, both for persons in nursing homes and those living 
at home. PCC staff also cooperate with authorities such as the Social Insurance 
Agency (Försäkringskassan) and the Public Employment Service 
(Arbetsförmedlingen) as well as patients’ employers. 
 
The real world – how to know what makes a difference 
The task of primary care is to grow as the population's needs grow and as more 
care is provided at the primary care level. We need to learn to develop primary 
care that is more effective for the user, society and, preferably, staff. This 
presupposes clinical research within the real world of primary care. Efficacy 
studies are performed under controlled/ideal conditions and answer the 
question Can it work? Effectiveness studies answer the question Does it work? 
Effectiveness studies of regular medical services that are designed to shed light 
on as many important aspects as possible are more likely to create value in the 
real world, which is a very complex system (24). Effectiveness studies are also 
known to be the most informative for drawing economic and cost-effectiveness 
conclusions (25).  
The WHO World Health Report 2008, entitled Primary health care. Now more 
than ever clearly articulates the need to mobilise knowledge on primary care 
level (26).  
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Depression in primary care 
Depression is a major source of human suffering and a great and growing 
challenge for societies worldwide. Mental health problems account for 13% of 
the global burden of disease and are one of the leading causes of disability (27). 
From an economic point of view, depression puts a high burden on affected 
individuals and also on society, including health care costs, sick leave and 
disability pension (28). The total annual cost of mood disorders in Europe in 
2010 was estimated at approximatively EURO 113.4 billion, which 
corresponds to almost 1% of the gross domestic product of the EU (29). The 
largest component of the costs of depression in Sweden consists of productivity 
loss due to impaired work performance. Depression is one of the leading causes 
of sick leave (30). The majority of people with depressive symptoms in 
Western countries – 70% in Sweden (31) – seeks and obtain treatment in 
primary care (30, 32). In Sweden approximately 15%-20% of primary care 
patients suffer from depression or a depression-like state (30). Only 20% of 
patients with depression are referred to specialist psychiatry (33). 
Primary care is the appropriate level for treating depression according to 
WHO, because it implies reduced stigma for mental health patients and their 
families, improved access to care, holistic management of co-morbidities, 
better treatment because of reduced losses to follow-up, lower patient-borne 
costs and improved overall capacity of the health care system to deal with 
mental health problems (28). 
 
The depression disease 
Existing national and international data on the prevalence of depression are not 
concordant; therefore, no reliable conclusion on the prevalence of depression 
in the general population can be drawn. For example, Swedish studies report 
the prevalence of depression in the general population of Sweden to be between 
2.4% and 15% (30). Women are more often diagnosed with depression than 
men (34), and the risk of becoming depressed increases with age, more so for 
women more than for men (35). There are several risk factors for depression 
such as chronic somatic disease, major life changes and traumatic events, 
heredity and substance abuse (30).  
The crucial difference between the brief mood swings of a healthy individual 
and depression is the quality of symptoms as well as the duration. A depression 
diagnosis is based on a clinical assessment in connection with the GP or 
psychologist consultation. ICD-10 (36) and DSM-IV (37) are the most 
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common systems of criteria for depression diagnostics internationally. The 
most used diagnostic criteria in Swedish primary care are the ones of ICD-10-
SE (38). ICD-10-SE defines depression as a condition that lasts more than two 
weeks and includes drowsiness, reduced energy and loss of interest or pleasure 
in activities that are otherwise satisfying. Sadness, anxiety, guilt, suicidal 
thoughts and reduced appetite may also be included (33).  
Depression is also associated with low quality of life, impaired functional 
capacity and work ability, sick leave, pain and increased risk of mortality (39, 
40). Patients with depression are also at risk of not receiving adequate 
treatment for concurrent somatic diseases resulting in deteriorated health and 
premature death (31).  
Regardless of the condition, depressed patients treated in the PCCs often 
function quite well and have capacity to work (41), unlike most patients in 
psychiatric secondary care. However, there are increasing numbers of people 
on sick leave for depression (42). In Sweden, a person can be on sick leave 
from work for one week without a sickness certificate. For a longer period of 
sick leave a sick note issued by a physician is needed. The employer pays 
benefits for the first two weeks of sick leave. Thereafter the Social Insurance 
Agency (Försäkringskassan) pays sick-leave benefits upon receiving an 
approved sick note. Part-time (25% -75%) or full-time sick leave is possible.  
 
Assessing level of depression 
There are several validated scales for assessing level of depression. The scales 
most used in clinical primary-care contexts are the self-rating version of the 
Montgomery Åsberg Depression Rating Scale (MADRS-S) (43) and the 
Patient Health Questionnaire 9 (PHQ-9) (44). The Beck Depression Inventory 
II (BDI-II) (45) is also used to a limited extent in primary care, but more often 
by psychologists and in research. The use of a self-assessment tool in recurrent 
consultations does not improve treatment results of depression in primary care 
compared to treatment as usual (TAU) (40, 46, 47), but it can strengthen the 
patient’s perceptions about clarification, centredness and confirmation (48) as 
well as increase adherence to anti-depressant medication (46).  
MADRS-S is used to assess the severity of depression and was developed as a 
self-rating version of MADRS. It is based on a questionnaire of nine items, 
each being valued from 0 (lower bound) to 6 (upper bound). Subscores are 
added for an overall score, which indicates the severity of depression (<12 = 
no depression, 13 - 19 = mild, 20 - 34 = moderate, ≥ 35 = severe).  
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BDI-II is a self-assessment instrument that measures the level of depression. 
The BDI-II contains twenty-one items, and the patient assigns each item a 
score of 0-3. Maximum score is 63. The cut-off for mild depression is 14, for 
moderate depression 20 and for severe depression 29.  
MADRS-S and BDI-II correlates well in assessing depression levels in all 
domains, but MADRS-S could be judged as a more rapid, inexpensive and 
easily administered tool compared to BDI-II (49). However, in clinical praxis, 
the BDI score of 29, classified as severe depression, seems to indicate a less 
severe condition than MADRS-S point 35 (49).  
 
Depression treatment and care according to the Swedish national 
guidelines 
The goal of all depression treatment is to free a person from the symptoms and 
regain a satisfactory level of functioning, including return to work. The 
severity of the symptoms determines whether the depression is graded as mild, 
moderate or severe. The severity together with the preferences of the patient 
then determines which treatment is appropriate. 
The Swedish National Guidelines for Care in Cases of Depression and Anxiety 
Disorders of 2017 ranked actions to be taken in assessing and treating mild to 
moderate depression (the ranking of action is based on the severity of the 
condition, the effect of the action/intervention, and the cost-effectiveness) (33). 
Among the recommendations with the highest ranks were: 
 High accessibility to health care for primary assessment. 
 Active follow-up with scheduled return visits (continuity). 
 Cognitive behavioural therapy (CBT). 
 Antidepressant medication. 
Thus, antidepressant medication and CBT are both recommended treatment for 
mild to moderate depression. However, there are studies showing that only a 
third of patients with – especially mild – depression fully respond to 
antidepressants (50), and that patients tend to favour psychotherapy to 
antidepressants (51). CBT is the form of brief psychological therapy with the 
strongest support in available evidence for persons with depression (31) and 
has been shown to be as effective as antidepressants in treating depression (30). 
Interpersonal therapy (IPT) is judged by a fraction of psychologists to be as 
effective as CBT, but there is less evidence on IPT. 
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In primary care, TAU for depression is based on the National Guidelines and 
consists of a diverse flora of treatment elements. The most appropriate 
elements are selected by the primary care team in close cooperation with the 
patient. TAU could include visits to the GP and/or nurse, antidepressants, face-
to-face psychotherapy (or waiting list for), sick leave, recommendations of 
increased physical activity or combinations of these. Care as usual (CAU) is a 
term used to describe the provided care as a whole including its organisation. 
Accessibility to and continuity of treatment for depression in primary care are 
well-known factors that increase the quality of care (33, 52). Continuity of care 
implies significant benefits to patients and staff (53). A Norwegian study in 
primary care showed that regularly occurring GP visits had a therapeutic effect 
similar to antidepressant medication (54). 
 
The need to break fresh ground  
The demands for accessible, continual, qualitative and coordinated health care 
are major challenges for health care and society to manage, given limited 
economic and personnel resources. There is a large gap worldwide between 
need and provision of depression care (28). Some of the main challenges facing 
the treatment and care of depression in primary care are related to accessibility, 
continuity and coordination. These challenges are especially relevant for 
depression and anxiety patients, whose symptoms often lower their access to 
care (55). 
Increases in funding and supply of educated personnel would probably 
improve opportunities to cope with the challenges in primary care. 
Nonetheless, new ways are needed to treat patients and cooperate within and 
between care levels. New evidence-based treatment methods and 
organisational forms of care need to be evaluated at the primary care level.  
Limited access and unacceptably long delays to psychotherapy is a severe 
problem for patients suffering from depression. The availability of CBT in 
primary care is low (31, 32), often due to a shortage of trained 
psychotherapists, and many patients therefore do not receive appropriate 
treatment (56). To be put on a waiting list for psychotherapy is a well-known 
disadvantage for recovery from depression and anxiety disorders (57). Patients 
also increasingly request online solutions for communication and treatment 
(58). Internet-mediated cognitive behavioural therapy (ICBT) has the potential 
to increase accessibility to CBT in primary care and to satisfy patients with 
requests for online treatment. 
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International studies conclude that isolated actions such as increased screening 
for depression, special training of doctors and nurses or increased 
psychological expertise in primary care do not result in higher quality of care 
or a better effect than CAU (59). Literature reviews by Cochrane and Swedish 
Agency for Health Technology Assessment and Assessment of Social Services 
(Statens beredning för medicinsk och social utvärdering (SBU)) have shown 
that only those organisational actions that include complex interventions have 
positive effects in reducing depression, improving patient satisfaction and 
quality of life compared to CAU in primary care (60).  
As most patients with depression are diagnosed and treated in primary care, 
studies that target the primary care context are especially needed. Relatively 
few studies have been conducted on the management of depression in primary 
care. Recommendations for diagnosis and treatment have mainly been based 
on research at psychiatric clinics, where few patients with mild and moderate 
depression are treated (30).  
 
Internet-mediated cognitive behavioural therapy – ICBT 
ICBT is an online alternative to standard manualized face-to-face CBT and is 
described as feasible, effective and acceptable (61). In standard ICBT patients 
regularly read and download online materials arranged into a series of lessons 
or modules available on a secure web-site during a specified period. They 
receive homework assignments to complete before the next module is 
available. They also complete questionnaires, allowing the therapist to monitor 
progress, safety and outcomes (62). ICBT allows greater access, and possibly 
more effective health care than face-to-face CBT (i.e. shorter therapist time 
spent per patient) (63). 
ICBT has been used as treatment for depression for many years (64-66) and is 
internationally accepted as a treatment for depression (63, 67-70). ICBT has 
been recommended by the National Board of Health and Welfare in Sweden 
(Socialstyrelsen) as the preferred treatment for mild to moderate depression 
(71). 
There are effectiveness studies of ICBT as treatment for depression in the 
primary care setting with the clinically most relevant comparison group, in 
other words, TAU (73, 74), but the evidence for Swedish primary care clinical 
practice is still insufficient (75).  
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Cost-effectiveness 
Several studies of the cost-effectiveness of ICBT as a treatment for depression 
have shown promising results in favour of ICBT (76-79). For example, 
McCrone et al. investigated the cost-effectiveness of ICBT compared to TAU 
in treating depression and anxiety in a randomised controlled trial (RCT) 
conducted in a primary care setting in the United Kingdom in 2004. They found 
that ICBT was more effective than TAU as provided by the primary care team 
at negligible additional cost. ICBT also reduced productivity loss caused by 
sick leave to lower levels than TAU (76). Recently, however, Gilbody et al. 
conducted an RCT concerning two different ICBT programs for depression in 
primary care in UK (the REEACT trial). No substantial improvement in 
depression outcomes could be seen compared to the usual GP care alone. The 
trial-based cost-effectiveness analyses suggested that none of the ICBT 
programs were cost-effective compared to usual GP care alone (74, 80). SBU 
has concluded that ICBT may be cost-effective, but whether it applies to 
Swedish primary care needs further investigation (75). 
Patient experiences 
How patients experience ICBT in the primary care context is important if we 
are to gain an understanding of the barriers and facilitators to successful 
treatment. Patients tend to be more positive to ICBT than psychotherapists 
(81). A study by Kivi et al (82) of the ICBT therapists’ experiences showed 
that they considered ICBT a complementary part of face-to-face therapy. There 
is evidence that care combining ICBT with face-to-face support is more 
effective than ICBT without it in community and secondary care (72, 83). 
Several studies of the patient experiences in ICBT (84-88) show the advantages 
and disadvantages of the treatment, but none have been made in the Swedish 
primary care context.  
 
Care levels in collaboration 
Collaboration, integration and coordination have become household terms. 
However, they do not mean the same thing to everyone. Cohen et al defined 
three interpersonal strategies (Cs) that primary care and behavioural health 
clinicians could practise to solve patients' problems: 
 Consult meaning seeking advice, confirm perceptions of a 
patient’s needs or validate care plans with another 
professional. 
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 Coordinate meaning two professionals giving care to a 
patient separately but cooperate in a parallel or back-and-forth 
fashion to achieve a common goal of the care. 
 Collaborate meaning two or more professionals interacting 
in real time to discuss a patient’s symptoms, communicating 
views on treatment and jointly develop a care plan. 
Cohen et al. suggested that organisations execute all three Cs routinely in 
practice (89). Wagner et al. suggested an integrated system of chronic illness 
care leaning on five cornerstones: the use of evidence-based, planned care; 
reorganisation of practice systems and provider roles; improved patient self-
management support; increased access to expertise; and greater availability of 
clinical information (91). This was further supported by WHO (28) and is the 
basis of the collaborative care model evaluated in this thesis. 
In the primary care and in the literature of the United States (where, however, 
the task and organisation of primary care is essentially different from in 
Sweden) there are several concepts involving collaboration, integration and 
coordination as follows.  
 Coordinated care is a broad term meaning organisation of 
patient care activities and information exchange between 
patient and provider, and between providers at different care 
levels.  
 Integrated care is an umbrella term that is defined by the 
American Psychiatric Association (APA) as ʻtightly 
integrated practice teams with a unified care plan. All aspects 
of the organisation and delivery of care are orchestrated to 
work effectively together to deliver whole-person careʼ 
(whole person care being ʻcare that is patient centred and 
addresses the full range of a patient’s medical and behavioural 
needs, culture, values and preferences; helps patients become 
active participants in their own health careʼ) (90).  
 Collaborative care is a form of integrated care which does 
not mean the same thing to everyone. The APA definition is 
ʻa specific type of integrated primary care that uses care 
registries and consulting psychiatrists to support a care team 
that includes a care coordinator and primary care physician 
typically located in the practice to treat common mental 
health conditionsʼ.  
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Collaborative care with a care manager 
To collaborate the core competencies of health care professionals for the 
patient is a well-established strategy of the primary care team. As mentioned 
above, Swedish primary care teams traditionally combine professions such as 
GPs, nurses, psychotherapists and physiotherapists. SBU recently published an 
evaluation of methods that can facilitate the introduction of evidence-based 
care for patients with depression in primary care (59). SBU identified an 
effective implementation strategy and referred to studies from the UK and US 
in which the primary care organisation was reinforced with a care manager and 
combined with other actions such as training of the care team and feedback 
between GP and patient. The care manager in these studies was described as a 
person especially trained for the task, such as a nurse, responsible for support 
and continual contact with patients with depression (60, 92). The care manager 
is a practice-based staff with direct patient contact, taking on the coordination 
and participate in both the clinical and nonclinical aspects of care. Care 
managers are sometimes referred to as care coordinators, patient navigators, or 
patient coaches (93). The care manager role referred to in this thesis has two 
types of important functions. One function is to increase accessibility and 
continuity of care for the patient at the PCC. The care manager then operates 
as a supporter and coordinator of care and not as a therapist. The other function 
is educational development at the PCC to improve communication and 
feedback within the PCC team and communication with secondary care (41, 
94, 95). 
SBU called for studies on collaborative care organisation with a care manager 
conducted in Swedish primary care (59), as complex interventions behave 
differently depending on context (96), and results from other health care 
systems may not be suitable for Swedish conditions. 
Cost-effectiveness 
Care managing has been shown to reduce patients’ depression symptom 
burden, to increase the adequacy of antidepressant prescription and to be cost-
effective both for the patient and the PCC (94, 97). Collaborative care was 
found to be cost-effective for the management of depressive disorders in a 
systematic review by Jacob et al. (92). Gilbody et al. concluded, in a systematic 
review of enhanced primary care for treating depression, that improved patient 
outcomes are expected in collaborative care, but at increased cost and 
investments (98). At present there are no Swedish studies of the cost-
effectiveness of a care-manager programme for the treatment of depression in 
a Swedish primary-care context. 
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Director and clinician experience 
The effect of implementation depends on the context and how the change 
process looks. Therefore, studies and systematic overviews should be 
complemented by methodologies that highlight contextual factors and the 
implementation process (59). Care manager interaction with patients and 
clinicians is affected by how well care management is defined and supported 
(97). Staff and organisational factors are known to be decisive for whether or 
not an implementation will succeed (99). According to previous studies, the 
facilitators of implementing collaborative care for depression in primary care 
are: strong leadership, standardised systematic clinical pathways, sufficient 
training and regular supervision of staff (95, 100) and accessible care managers 
on site (94, 97). The social and professional skills of the care managers are 
additional facilitating factors (101). Existing service structures, unfavorable 
financial structures (97, 100) lack of organisational, administrative and 
professional ability to change and implement, and lack of clarity of the 
responsibility of the care manager (102, 103) are barriers. At present there are 
no published Swedish studies on the experiences of staff in a care manager 
programme for the treatment of depression in a Swedish primary-care context. 
 
Cost-effectiveness in health care 
The Swedish health-care system abides by the priority principles of human 
dignity, need and solidarity, and cost-effectiveness. It is committed to ensuring 
the health of all citizens (21). Previously, clinical effectiveness was the only 
thing that counted in the field of medical research; and prioritization of 
resource use was not always necessary. Now we spend more money on health 
care than ever, and health-care resources are continual insufficient. 
Prioritization is unavoidable. The pressed budgets of the past two decades have 
granted economic evaluations increased prominence in health-care decision 
making (25). These evaluations provide frameworks for making the best 
economic use of clinical evidence through organised considerations of the 
health effects of available alternatives and health care costs.  
The most commonly used form of economic evaluation in the field of primary 
care is the cost-effectiveness analysis (25). This method evaluates 
benefits/effects of alternative interventions/options relative to costs.  
Some key concepts of cost-effectiveness analysis are described below. 
 
Aspects of cost-effectiveness and feasibility of primary care implementations 
16 
Health care and societal perspectives  
Perspective must be considered when deciding which costs and health benefits 
to include in an economic evaluation. One perspective could be the 
individual’s; for example a cost could be what the patient needs to buy or pay 
to be healthy (out-of-pocket costs). In the Swedish context, however, health 
care (i.e. the county council) pays the lion’s share of costs related to 
investigation and treatment of disease. In economic evaluations health care 
represents the payer.  
The health care perspective comprises the payer’s costs. In the example of 
depression, these costs might include the labour of health care personnel (e.g. 
GPs, psychotherapists and nurses), investigation (e.g. basic blood samples), 
treatment equipment (e.g. ICBT software) and medication.  
The societal perspective includes the health care perspective but adds costs and 
benefits on a national level. Thus, the societal perspective includes all costs 
and effects related to the condition or disease irrespective of how and when 
they emerge. In the example of depression, societal costs might consist of 
production loss related to sick leave and/or health care visits and treatment. 
See Figure 1.  
Figure 1. Costs from a societal and a health care (i. e. payer’s) perspective. By Anna 
Holst, 2018. 
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Pricing time  
Health care costs 
In primary care the most valuable and most costly resource is the health care 
personnel (whereas in some secondary care, the medication or technical 
devices may comprise a larger part of the cost). Assessing the cost of an 
intervention therefore mainly involves the identification and valuation of 
utilizing health-care personnel (e.g. time spent on patient contact, treatment 
and follow-up). The cost of this utilization is calculated by combining salary 
data (gross wage plus social fees) per hour – defined as the hourly wage – with 
time spent (25). For example the cost of a 45-minute GP consultation 
equals hourly wage 653 SEK x


= 490 SEK. 
Average standard costs are listed for several posts, such as GP visits. However, 
the actual time spent, if obtainable, would be more accurate in calculating true 
costs as described above. 
Societal costs 
The human capital approach (25) can be used to put a value on the productivity 
lost to illness and sick leave. This approach values work/productivity at the 
market price of what an employer is willing to pay per hour of labour (gross 
wage plus social fees). Some health economists claim that the human capital 
approach overestimates the value of productivity loss and advocate instead for 
the friction cost approach (104). Friction cost arises in the time period during 
which no one is producing. The friction cost starts when someone falls out of 
production and ends when replaced by another person. 
The hourly wages of patients could be calculated from individual salary data 
or average gross wages for the context (in this case Sweden). 
 
Quantifying health and life  
To measure the health benefits of an intervention, disease-specific outcome 
measures can be used. (See Assessing level of depression, page 8). A benefit 
of disease-specific instruments, such as MADRS-S and BDI-II, is that they are 
used clinically to evaluate depression and can capture relatively minor changes 
in the disease state. The disadvantage, in assessing cost-effectiveness, is that 
the score is not translatable to other medical care, and there is no way to 
determine an effective cost-effective limit based on differences in points. 
Additionally, MADRS-S and BDI-II present only a snapshot of depression 
symptoms. Depression-free days (DFDs) (105) is a measure that 
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simultaneously captures treatment outcome and estimates the patient's 
experience of depression over time. DFDs are calculated by using linear 
interpolation to estimate daily depression severity across assessment points. In 
this manner, each day in the follow-up period is assigned a depression level, 
and days without depression can be counted using diagnostic instruments such 
as MADRS-S. DFDs are understood by clinicians and decision makers and are 
used in several cost-effectiveness studies of depression intervention (106).   
In cost-effectiveness analysis, quality adjusted life years (QALYs) is 
recommended as an outcome measure (107, 108). QALYs is a tool developed 
in the US and Canada during the late 1960s (109) to evaluate the cost-
effectiveness of treatments. It is central to health-care decision making in many 
countries. QALYs measures a person’s health state regarding both health 
related quality of life (HRQoL) and length of life. The EuroQol, five-
dimension, three-level (EQ-5D-3L) self-assessment instrument (110) is one of 
the generic preference-based measures used to assess HRQoL. A person uses 
EQ-5D-3L to assess health status in five dimensions (mobility, self-care, 
ability to undertake usual activities, anxiety and depression), with three levels 
of health state (no problems, some problems, extreme problems) in each 
dimension (111). Responses to the EQ-5D-3L instrument can be inserted in the 
index scale based on the often-used Dolan-tariff (112) and be assigned QALY 
weights. QALY weights can vary between 1 (perfect health) and 0 (death) (25). 
The sum of QALY weight values over a period of time, such as a depression 
episode, is calculated as the area under the curve as illustrated in Figure 2. 
 
Time perspective 
It is important to choose an evaluation period that is long enough to capture all 
relevant consequences of the intervention. Clinical knowledge and prior 
studies can provide important input to this decision.  
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Figure 2. Example of QALY calculations. The two QALYs (control and intervention) 
are represented by the areas under the curves; blue area for the control and blue 
area plus brown area for the intervention. The brown area represents the difference 
in QALYs (ΔQALYs). By Anna Holst, 2018. 
 
Comparison of alternatives – the ICER  
In a cost-effectiveness analysis, costs and effects (health outcomes) of 
treatment options are compared to each other. The result is expressed as the 
incremental cost-effectiveness ratio (ICER) (25). The ICER is defined by the 
difference in cost (Δcost) between two possible treatments (e.g. intervention 
vs control/TAU/CAU) divided by the difference in their effect (Δeffect) (see 
example in Figure 2 where Δeffect (ΔQALYs) is represented by the brown 
area) calculated as: 
  = ∆!"#$ ∆%&&%!$' = 〖"#$〗_)*$%+,%*$)"* −〖"#$〗_!"*$+".) ⁄ 
(〖2%3.$ℎ "5$!"6%〗_)*$%+,%*$)"* −〖2%3.$ℎ "5$!"6%〗_!"*$+". ) 
The ICER can be viewed as the price tag of a one unit increase in the health 
outcome measure (e.g. BDI-II score or QALYs). When prioritizing treatment 
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options, larger patient health gains may be achieved at a given budget if 
treatments with a lower ICER are recommended.  
 
Visualization of cost-effectiveness – the cost-effectiveness plane  
The cost-effectiveness plane (Figure 3) is used to visually represent the costs 
and effects of treatment options in two dimensions. Effects are plotted on the 
x axis and costs on the y axis (see ICER example V). The control/TAU/CAU 
is frequently plotted at the origin, so the x and y values represent incremental 
effects and incremental costs vs control/TAU/CAU.  
 
Figure 3. The cost-effectiveness plane. By Anna Holst, 2018.  
SW=south-west, NW=north-west, NE=north-east, SE=south-east, 
WTP=willingness to pay, ICER=incremental cost-effectiveness ratio 
The cost-effectiveness plane is divided into four quadrants. Most cost-
effectiveness analyses of new treatments show results in north-east (NE) 
quadrant (ICER example Z), meaning the new treatment generates more health 
but is also more expensive. Results in the south-east (SE) quadrant (ICER 
example X) should be accepted right away, as they are more effective and less 
costly. On the other hand, results in the north-west (NW) quadrant (ICER 
Anna Holst 
21 
example Y) should be rejected as they are both less effective and costlier. In 
the NE (ICER example Z) and the south-west (SW) (ICER example V) new 
treatment are assessed as cost-effective if below the willingness-to-pay (WTP) 
threshold (ICER example Z). The WTP threshold is defined as the decision 
makers’ WTP for one health outcome unit, e.g. one QALY. The WTP threshold 
could be seen as a rule for determining whether an intervention should be 
implemented or not. WTP thresholds differ between countries and contexts. In 
Sweden there is no clearly defined WTP threshold, but National Board of 
Health and Welfare (Socialstyrelsen) have in some guidelines mentioned 
500,000 SEK per QALY (113). Compare this with the UK NICE (National 
Institute for Health and Care Excellence) WTP of GBP 30,000 (347,000 SEK) 
per QALY (114).  
 
Assessing uncertainty 
The certainty of parameter estimates in data from trials is often too limited to 
enable a robust cost-effectiveness analysis. Sensitivity analysis of data should 
therefore be performed to quantify the level of confidence in the output of the 
analysis, in relation to uncertainty in the input data. Probabilistic sensitivity 
analysis (e.g. non-parametric bootstrapping) is often the method of choice 
when data are available on an individual level. This analysis is executed as a 
trial where random draws from input data are made, and the ICER is calculated 
from each draw. This is repeated many times (typically 1,000 to 10,000), 
resulting in a distribution of resampled ICERs that can be graphed as a cloud 
on a cost-effectiveness plane. It could also be presented on a cost-effectiveness 
acceptability curve illustrating the probability of an intervention being cost-
effective for several WTP threshold values per health outcome unit (25).  
Deterministic sensitivity analysis, or scenario analysis can be used to assess 
how cost-effectiveness would be affected by changes in relevant assumptions 
(e.g. different price levels of the ICBT programme).  
The distribution of ICERs could be difficult to interpret if it spanned the 
dominant SE quadrant (lower costs and better health outcomes) and the 
dominated NW quadrant (higher costs and worse health outcomes). In that case 
it would be recommended to estimate the net monetary benefit instead (25).  
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Net monetary benefit 
Net monetary benefit (NMB) translates the cost-effectiveness calculation into 
a linear expression and is calculated as: 7 × ∆%&&%!$ − ∆!"#$, where V is the 
WTP threshold value per health outcome unit (e.g. BDI-II score or QALY). If 
NMB is positive, the treatment is cost-effective; if the NMB is negative, the 
treatment is not cost-effective. 
For example, imagine that the mean health gain of ICBT compared to TAU is 
0.1 QALYs (Δeffect) with an associated increase in costs of €1,000 (Δcost). 
Assume that the decision maker’s WTP per QALY (V) is €30,000. In this 
situation, the ICER is €1,000 ∕ 0.1 = €10,000, whereas the NMB = (€30,000 × 
0.1) - €1,000 = €2,000; in other words, it is positive. The conclusion is identical 
whether we look at the ICER or at the NMB – ICBT is cost-effective – because 
the ICER is below the decision maker’s WTP per QALY and the NMB is 
positive. Conclusions based on the ICER and the NMB will always be 
identical, but the advantage of the NMB expression is that we do not confuse 
dominant with dominated outcomes and can therefore always calculate 
appropriate confidence intervals. 
Probabilistic sensitivity analysis can also be used to assess the uncertainty of 
the NMB result as in the case of ICERs (115). 
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Aim 
General aim 
The aim of this thesis was to evaluate internet-based treatment and 
collaborative care organisation with a care manager in the primary care setting 
– examples of two implementations intended to raise the quality and quantity 
of treatment and care for patients with mild to moderate depression in Swedish 
primary care, from the perspectives of cost-effectiveness and patient and staff 
experiences.  
Specific aims 
I. To perform an economic evaluation of internet-mediated cognitive 
behavioural therapy (ICBT) compared to treatment as usual (TAU) as 
treatment for mild to moderate depression in the primary care setting, based on 
a pragmatic effectiveness trial performed in Swedish primary care. In 
particular, the objective was to assess the incremental cost-effectiveness ratio 
(ICER) of ICBT vs TAU at twelve-month follow-up, from health-care and 
societal perspectives. 
II. To explore primary care patients’ experiences of ICBT depression 
treatment. 
III. To evaluate the cost-effectiveness of a care manager programme compared 
with care as usual (CAU) for treatment of mild to moderate depression in the 
Swedish primary care setting from health-care and a societal perspectives. 
IV. To study primary health care clinicians’ and directors’ perceptions of 
implementing collaborative care with a care manager for patients with 
depression at the PCC. And secondly, to identify the barriers and facilitators, 
perceived by the personnel, influencing this implementation. 
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Figure 4. Word-cloud representing the most used words of the thesis. By Anna Holst, 
2018. 
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Methods 
Table 1. Summary of designs, materials and methods of the included 
studies. 
 Design Study group Data collection  Data analysis 
Paper 
I 
Cost-
effectiveness 
analysis 
alongside a 
pragmatic 
effectiveness 
trial  
16 PCCs in 
Region Västra 
Götaland; 90 
patients 
diagnosed with 
depression at 
the PCCs   
Electronic patient 
records, patient 
research 
questionnaires 
(PRIM-NET), 
salary databases, 
drug pricing 
database  
Cost-
effectiveness 
analysis 
Paper 
II 
Qualitative 
cross-sectional 
study 
13 patients 
having received 
ICBT for 
depression 
Focus groups and 
semi-structured 
individual 
interviews 
Systematic text 
condensation 
according to 
Malterud 
Paper 
III 
Cost-
effectiveness 
analysis 
alongside a 
pragmatic 
cluster 
randomised 
controlled trial  
23 PCCs in two 
regions of 
Sweden; 376 
patients 
diagnosed with 
depression at 
PCCs  
Electronic patient 
records, patient 
research 
questionnaires 
(PRIM-CARE), 
salary databases, 
drug pricing 
database 
Cost-
effectiveness 
analysis 
Paper 
IV 
Descriptive 
and qualitative 
cross-sectional 
study 
36 strategically 
selected PCCs 
with care 
managers in 
Region Västra 
Götaland; 36 
directors and 
461 clinicians  
Web-based 
questionnaires 
Descriptive 
statistics and 
inductive 
manifest content 
analysis 
according to 
Graneheim et al. 
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The PRIM-NET study 
The PRIM-NET study was a pragmatic effectiveness trial comparing ICBT to 
TAU as treatment for mild to moderate depression in Swedish primary care. It 
evaluated depressive symptoms, quality of life and sick-leave results in a three, 
six and twelve-month evaluation (116, 117).  
The PRIM-NET study was conducted in the region of Västra Götaland (with 
about 1.6 million inhabitants) in 2010-2014. All the PCCs in the region, with 
a CBT psychotherapist on the team, were invited to participate in the study. Of 
those, sixteen PCCs (twelve urban and four rural, twelve publicly run and four 
privately) accepted, and were included. GPs and nurses at the PCCs were 
instructed to invite all patients aged eighteen years and older who had a 
probable diagnosis of mild to moderate depression to the study. Depression 
diagnosis was based on DSM-IV criteria and grading of depression was based 
on the MADRS-S score. Exclusion criteria were severe psychiatric disorder, 
suicidal ideation or anamnesis of suicidal attempt, cognitive disability, 
substance abuse or insufficient knowledge of the Swedish language (116, 117).  
Included patients were randomised to ICBT or TAU. TAU patients received 
the treatment typically provided at the specific PCC. TAU could consist of 
visits to a GP, nurse, antidepressants, face-to-face psychotherapy, sick-leave 
certification or combinations thereof. Patients randomised to ICBT received 
access to a commercially available ICBT treatment program 
(Depressionshjälpen®) based on CBT techniques, consisting of seven modules 
accessible throughout the treatment period of twelve weeks. The modules were 
completely self-help. Contact with a psychotherapist was established once a 
week via secure email and concentrated on validating the patient, reinforcing 
progress and encouraging the patient to continue working in the programme. 
The ICBT patients could also receive components of TAU treatment, excepting 
non-ICBT psychotherapy (116, 117). 
 
Paper I – Cost-effectiveness analysis of ICBT vs TAU  
This study was conducted alongside the PRIM-NET pragmatic effectiveness 
trial (116, 117). Practice and participant recruitment is described above. 
Health outcomes  
Changes in health status were assessed in terms of QALYs and BDI-II scores. 
Data were available at baseline and at three, six and twelve months post-
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baseline. QALYs were calculated based on EQ-5D-3L scores and the time 
spent in each health state, according to the Dolan tariff (112). Adjustments 
were made for differences in baseline EQ-5D-3L scores of the two groups 
(118). Statistical significance was set at p < 0.05. 
 
Cost outcomes 
Costs were identified and valuated as follows: 
Health care utilization. The amount of visits and phone-counselling events with 
GPs, nurses and psychotherapists were retrieved at the individual patient level 
from electronic patient records (EPR). Hourly wages were based on market 
prices from databases (119, 120). 
Intervention. The costs of intervention included the ICBT software and the 
working hours of the psychotherapist. The cost of the ICBT software was 
defined as the market price of similar, commercially available programs. 
Medication. Drug consumption was retrieved from EPR and patients’ 
questionnaires. Drug costs were based on prices retrieved from the Dental and 
Pharmaceutical Benefits Agency (TLV) (121). 
Productivity loss. The human capital approach (25) was used to measure and 
value the costs of productivity loss. Sick-leave data were patient-reported. 
Patients’ hourly wages were calculated using individual income data from the 
Tax Directory 2013 and were multiplied by the total hours of sick leave to 
obtain a value for productivity loss.  
Patient costs. Transportation time and transportation expenses were calculated 
using the postal codes of the PCCs and the patients’ residential addresses. 
 
Cost-effectiveness analysis  
The economic evaluation was made from a health care – that is, the payer’s – 
perspective, encompassing resource use of health care, intervention, and 
medication. From a societal perspective, it included the resource-use 
consequences of productivity loss and patient costs. No discounting was 
applied since all costs (and health outcomes) analysed were within a one-year 
period. 
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We estimated ICER and NMB for the cost-per-reduced score on the BDI-II 
scale and the cost per QALY at the twelve month follow-up. To assess 
uncertainty, deterministic sensitivity analyses were carried out using scenario 
analysis, (i.e. changing relevant assumptions in different analyses to assess 
how they affected cost-effectiveness). To assess sampling uncertainty, 
confidence intervals of the NMB were constructed using probabilistic 
sensitivity analysis (non-parametric bootstrapping with 1,000 bootstrap 
resamples) of the observed data (115). Data analysis was carried out in 
Microsoft Excel. 
 
Paper II – Patients experiences of ICBT – qualitative analysis 
Upon closing the PRIM-NET pragmatic effectiveness trial (116, 117) the ICBT 
patients were invited to participate in a focus group discussion about their 
experiences. Of the thirty-six contacted, seventeen were interested in 
participating and thirteen were included. We went through with one focus 
group of four patients and one of two (two cancelled immediately preceding 
the set appointment). Seven patients were individually interviewed. Data were 
collected by independent researchers who had not been involved in the 
patients’ ICBT treatment. Time from end of treatment to interview varied 
between one and thirty-six months. A topic guide was developed for focus 
groups and interviews based on study objectives. An interview guide used in 
ICBT research at Linköping University was used as inspiration (122). A semi-
structured interview guide (123) was developed for the individual interviews.  
The focus group discussions were led by one moderator and one observer. 
Open-ended questions were used inviting the patients to talk about their own 
experiences of ICBT. Questions such as How would you describe ICBT? or, 
How did you perceive the Internet as a treatment context? or What did you 
experience at the end of your ICBT treatment? served to enrich and deepen 
data collection. Each meeting lasted no longer than 1.5 hours. All sessions were 
audiotaped and transcribed verbatim.  
Data were analysed by systematic text condensation (STC) according to 
Malterud (124), as inspired by Giorgi’s phenomenological approach (125), 
which is developing descriptions and concepts concerning ICBT experiences. 
STC was chosen because it aims to describe the experiences of informants, as 
they express them, rather than explore the possible underlying meaning of their 
statements. Before starting the analysis, the analysers identified their 
preconceptions about depression treatment and ICBT in order to bracket 
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previous ideas and knowledge. The process involved four steps: I. Reading all 
the material several times to obtain an overall impression. II. Identifying units 
of meaning, representing different aspects of the research question, and coding 
and sub-coding them. III. Condensing and summarising the contents of each 
of the coded groups. IV. Generalising descriptions and concepts reflecting the 
informants’ most important experiences of ICBT. One of the focus group 
discussions was coded by two analysers separately to assure analysis quality, 
and the codes were set after thorough discussions between analysers. Analysis 
was data-driven, but in the last step the relevance of our findings was assessed 
by comparing them to existing studies (85, 126, 127). 
 
The PRIM-CARE study 
The first wave of implementation on collaborative care with a care manager 
(CCCM) was performed as a pragmatic cluster randomised controlled trial – 
PRIM-CARE – to obtain a thorough evaluation of CCCM in Swedish primary 
care. The RCT format was chosen to enable further adaptation of CCCM to 
patient and staff considerations and their perceptions of the organisational 
change. (See Figure 5.) The CCCM intervention was compared to CAU as a 
treatment in Swedish primary care for mild to moderate depression and 
evaluated depressive symptoms, quality of life and sick-leave results in a three, 
six and twelve-month evaluation (41). 
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Figure 5. The two implementation waves of CCCM including the PRIM-CARE RCT 
in first wave. By Anna Holst, 2018. CAU, care as usual; CCCM, collaborative care 
with a care manager; GU, Gothenburg university; PCC, primary care centre; RCT, 
randomised controlled trial; VGR, Region Västra Götaland. 
The PRIM-CARE study was conducted in Region Västra Götaland and Region 
Dalarna in 2014-2016. All the PCCs in Västra Götaland that did not have an 
on-site position comparable or equal to care manager were invited to 
participate in the implementation CCCM. In Västra Götaland, 160 PCCs 
expressed interest in participating in the implementation of a care manager and 
twenty-three urban and rural PCCs accepted to be included in the RCT as well. 
Four PCCs in Dalarna also were interested and included. Randomisation to 
CCCM or CAU was carried out at the PCC level. 
The GPs and nurses at the PCCs were instructed to invite all patients aged 
eighteen years and older with a diagnosis of mild to moderate depression to the 
study. The depression diagnosis was based on ICD-10 and graded according to 
its MADRS-S score. Exclusion criteria were severe psychiatric disorder, 
suicidal ideation or anamnesis of suicidal attempt, cognitive disability, 
substance abuse or insufficient knowledge of the Swedish language (41). 
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PCCs randomised to CAU provided treatment – typically at the PCC – 
according to the Swedish National Guidelines for Depression and Anxiety 
Disorders, which recommend a stepped care model with easily accessible and 
continual care, short intervals between follow-up appointments, guided self-
help, CBT, interpersonal therapy and/or antidepressants (71). 
CCCM intervention PCCs each established a nurse as a care manager who used 
20% – 25% of her/his working time to coordinate and manage the care and 
support of patients with depression. Before the study started, participating staff 
members were educated as to their tasks in the care manager programme (two 
days for GPs, five days for nurses/care managers and one day for PCC 
directors). Programme services for participating patients included an 
individual care plan (one hour session per patient with care manager), regular 
telephone contact between care manager and patients to assess self-rated 
depressive symptoms (at least six to eight times during the twelve-week 
intervention period) and the opportunity to contact the care manager at any 
point (unscheduled) if needed. Furthermore, care managers were in constant 
dialogue with GPs, psychotherapists and other health care personnel in 
following up patients. Thus, care managers did not perform any 
psychotherapeutic measures beyond behavioural activation; they were a 
supportive link between specialists and patients while improving accessibility 
and continuity of care, as well as treatment adherence. In addition, care 
managers had regular follow-up meetings (every second month) during the 
study, to discuss difficulties and successes with the research team and the 
region’s implementation team (41).  
 
Paper III – Cost-effectiveness analysis of collaborative care 
with a care manager vs CAU  
The study was conducted alongside the PRIM-CARE RCT (41). Practice and 
participant recruitment is described above.  
Health outcomes 
Main health outcome measure were DFDs calculated from depressive 
symptoms expressed as change in MADRS-S, and QALYs based on EQ-5D-
3L scores and the Dolan tariff (112). The number of DFDs was assessed by 
estimating the number of days each patient scored below 12 on the MADRS-
S.  
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Cost outcomes 
As in Paper I costs were estimated both from a health care perspective, 
considering health care costs, and from a societal perspective, which added 
productivity loss to health care costs. Costs were identified and valuated as 
follows: 
Health care utilization. The amount of visits and phone counselling events 
involving GPs, nurses and psychotherapists were retrieved at individual patient 
level from EPR and patient research interviews/questionnaires in PRIM-
CARE. Health care costs included the costs of educating PCC personnel for 
the intervention group. Costs per health care contact and for staff education 
were calculated by means of time spent and gross wages (including social fees) 
of the respective professional groups (119). 
Medication. Drug consumption was retrieved from EPR and patients’ 
questionnaires. Drug costs were estimated based on prices retrieved from the 
Swedish Pharmaceutical Industry Association’s Service (LIF) (128). 
Productivity loss. The human capital approach (25) was used to measure and 
value the costs of productivity loss, which were calculated using EPR and 
patient-reported sick-leave data (percentagewise) during the follow-up period 
and the average gross wage (including social fees) of women in Sweden (since 
almost two-thirds of the study population were female).  
 
Cost effectiveness analysis 
The economic evaluation was made from both health-care and societal 
perspectives. No discounting was applied since all costs (and health outcomes) 
analysed occurred in less than one year. 
The ICER was calculated as the ratio of differences in mean costs per patient 
and mean QALYs (∆Costs/∆QALYs) or mean DFDs per patient 
(∆Costs/∆DFD), respectively, between the intervention group and the CAU 
group at the six-month follow-up. Because the design was a cluster randomised 
study, the difference in effect and costs was analysed using a multi-level model 
of patients nested in the PCCs. Patients were included (342 of 376) if data were 
available for baseline and at least one follow-up assessment. Missing values at 
the three- or six- month follow-up were imputed from a linear regression 
analysis combining non-missing EQ-5D-3L data with individual 
characteristics (age, sex, education level, ethnicity, marital status) as 
predictors. Data analysis was carried out in Microsoft Excel and Stata v.15.  
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To assess sampling uncertainty non-parametric bootstrapping (25) was used to 
focus on the cost per QALY. ICERs for both health outcome measures were 
estimated based on 5,000 bootstrap resamples and summarised in a cost-
effectiveness plane and a cost-effectiveness acceptability curve (CEAC). For 
the cost-effectiveness plane we showed confidence ellipses of the areas 
containing 95%, 75% and 50% of the bootstrapped ICERs, together with the 
point estimates from the main analysis. To eliminate the difficulty of 
interpreting negative ICERs, the net monetary benefit was estimated and used 
to construct the CEAC. 
 
Paper IV – Director and clinician experiences of collaborative 
care with a care manager – descriptive and qualitative 
analysis   
In July 2016 the second wave of implementation (see Figure 5.) was ongoing 
and 83 of the 200 PCCs operating in Region Västra Götaland had established 
a care manager for depression. A stepped strategic sampling of these 83 PCCs 
was made. The first division was geographical, the second was a subdivision 
into city/urban/rural and the third was subdivision into privately or publicly 
run PCCs in each area.  
The study population were two groups of participants: clinicians (of any 
profession) and directors of the PCCs from the strategic sampling. The PCCs’ 
care managers were not invited. 
Two different questionnaires were used to capture experiences from the 
horizons of clinicians and directors, respectively. The questionnaires had been 
pilot tested. 
The first part of both questionnaires consisted of questions about background 
characteristics. The statements in the second part were developed from 
questionnaires used in previous studies of the same context, evaluating the 
Swedish rehabilitation guarantee (129-131). Additional questions were related 
to the Consolidated Framework for Implementation Research (CFIR) guide 
(132, 133). The CFIR is an over-arching theoretical framework useful for 
implementation research. The CFIR includes 39 constructs known to be 
relevant for implementation organised into five domains: intervention, outer 
setting, inner setting, characteristics of individuals and process. 
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In the clinician questionnaire, the statements addressed factors potentiating 
care manager implementation as well as facilitators and barriers of cooperation 
with the care manager. Open-ended questions were included. In the director 
questionnaire, the statements addressed care manager implementation as well 
as facilitators and barriers of introducing the care manager position. The 
questionnaires were distributed to the participants by email (including several 
reminders) and data were gathered during two months in 2016.   
Quantitative data were analysed in SPSS version 24.0. Descriptive statistics of 
the items, for directors and clinicians separately, were compiled for the 
following groups: I. The study population as a whole. II. The treating and 
administrative professionals (for the clinicians’ result only). III. The staff 
working at small and large PCC units. IV. The staff working at city, urban and 
rural PCC units. 
Qualitative analysis of the free text answers of the open-ended questions was 
made by inductive manifest content analysis according to Graneheim et al 
(134, 135). The process contained four steps: I. The free text in each question 
area was compiled separately for the PCC directors and the PCC clinicians. II. 
The material was read through several times, and with the objective in focus, 
meaning units were identified. III. The meaning units were compared to each 
other, abstracted and labelled with codes. IV. The codes were compared to each 
other based on differences and similarities and grouped into categories with 
subcategories representing similar meanings, which constituted the manifest 
content.  
Data analysis was performed by one of the authors. For improved 
trustworthiness, the codes, categories and subcategories were discussed with 
the other members of the research team which represented different 
professions. 
 
  
Anna Holst 
35 
Ethical issues 
Health care has a responsibility to maintain a balance between biomedical and 
humanistic approaches to health, illness and disease. Interventions of 
disputable benefit should be avoided. In reality, health care and society do not 
always live up to these central ethical principles, for example by – outside 
research environments – exposing individuals to non-evaluated interventions. 
The studies of this thesis have been conducted according to the Declaration of 
Helsinki. After being provided oral and written information about the studies 
prior to inclusion, participants signed written informed consent. They were 
informed that they at any time during the study could withdraw without reason 
and without consequences for future care. The participants were also assured 
that all information they provided would be handled confidentially. The 
researchers made an effort to be observant and respectful during the interviews. 
If a participant was in need of emotional support or healthcare, the researcher 
assisted with further guidance. 
Papers I and II – PRIM-NET – Ethical approval was given by the Regional 
Ethical Review Board in Gothenburg, Sweden (Dnr 2010/696-09 and 
supplement 2014/T033-14).  
Papers III and IV – PRIM-CARE – Ethical approval was given by the Regional 
Ethical Review Board in Gothenburg, Sweden (Dnr 2014/903-13 and 
supplements 2015/T963-15, 2015/T975-14, 2016/T403-15).  
         
Temppellaukio kirkko, Helsinki                                                                                    Photo: Chris Walton 
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Results 
Paper I – Cost-effectiveness of ICBT vs TAU 
The baseline characteristics of the 90 patients constituting the primary sample 
of PRIM-NET (117) are shown in Table 2. PRIM-NET was designed as an 
RCT in which all included patients were supposed to be randomised to TAU 
or ICBT. However, we had difficulties recruiting patients, because we only 
recruited those who were attending primary care with a new depression and 
also positive to ICBT. Therefore, eight patients randomised to TAU were 
transferred to the ICBT group at the end of the recruitment period to achieve a 
higher number ICBT-treated individuals at the twelve-month follow-up. That 
is, PRIM-NET could be categorised as an RCT only for the first three months 
of follow-up. For the twelve-month follow-up we categorised it as a controlled 
study without randomisation.  
The ICBT and TAU-groups were closely comparable.  
 
 Better work outside than locked in a room                               Photo: Nell’s journey 
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Table 2. Baseline characteristics of the PRIM-NET patients.  
 
ICBT 
(n=52) 
TAU (n=38) p-value 
difference 
 in 
means/propo
rtions 
Woman, n (%) 31 (60) 39 (75) 0.16 
Age, mean (SD) 39 (13) 38 (10) 0.63 
Living alone, n (%) 24 (46) 13 (38) 0.44 
University level education, 
n (%) 
19 (37) 9 (24) 0.19 
High socioeconomic 
status,* n (%) 
28 (65) 18 (60) 0.63 
Employed, n (%) 38 (73) 29 (78) 0.59 
On sick-leave during past 
year, n (%) 
24 (46) 15 (39) 0.51 
Income years (SEK), mean 
(SD) 
290,885 
(93,094) 
268,496 
(60,508) 
0.20 
*According to SEI (socioeconomic index). ICBT, internet-mediated cognitive behavioural 
therapy; TAU, treatment as usual; SEK, Swedish kronor (1 SEK~ €0.105). 
 
For the cost-effectiveness analysis we only included patients with sufficient 
cost and outcome data which resulted in 40 ICBT patients and 33 TAU 
patients. In both the ICBT and the TAU groups, the excluded cases were 
relatively healthy patients with low levels of care consumption.  
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Health outcome  
In both ICBT and TAU groups, the reduction of depressive symptoms was 
significant (117) with reduced BDI-II scores and increased EQ-5D-3L scores 
(see Table 3). The TAU group had slightly better results but the differences 
between the groups were not statistically significant.  
The mean total QALYs was 0.74 for the ICBT group and 0.79 for TAU. We 
adjusted for the minimal difference in EQ-5D-3L scores at baseline (the ICBT 
group scored a little higher than the TAU group) with no statistical 
significance.  
 
Table 3. Health outcomes. Means and 95% confidence intervals (in 
parentheses). 
 BDI-II EQ-5D-3L score 
 ICBT TAU ICBT TAU 
Baseline 24.38 
(21.77;26.98) 
25.66 
(21.98;29.33) 
0.66 
(0.59;0.73) 
0.61 
(0.52;0.70) 
12 months 10.97 
(7.66;14.28) 
11.83 
(8.29;15.36) 
0.79 
(0.72;0.87) 
0.81 
(0.75;0.87) 
Within-group 
change 
-13.40  
(-17.5;-10.5) 
-13.83  
(-17.90;-0.17) 
0.13 
(0.05;0.21) 
0.19 
(0.12;0.28) 
Between-
group change  
(ICBT-TAU) 
 
-0.46 (-5.83;4.91) 
 
-0.07 (-0.18;0.04) 
Total QALYs* - - 0.74 
(0.75;0.84) 
0.79 
(0.70;0.78) 
*Adjusted for baseline difference in the EQ-5D-3L score. No differences between ICBT and 
TAU were statistically significant. The within-group changes were statistically significant for 
both ICBT and TAU (for both BDI-II change and EQ-5D-3L score change). 
BDI-II, Beck depression inventory-II; EQ-5D-3L, EuroQol five-dimension; ICBT, internet-
mediated cognitive behavioural therapy; TAU, treatment as usual; QALYs, quality-adjusted life 
years. 
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Cost outcome 
A detailed overview of cost identification, valuation, and distribution is 
presented in Table 4. There were no statistically significant differences 
between the two groups concerning total health care costs, total non-health care 
costs or total societal costs per patient. No patients were referred to psychiatric 
care. All costs were expressed at the 2013 price level.  
 
Table 4. Mean health care, non-health care and total costs during the 
twelve follow-up months.  
Cost items  Cost/ 
unit 
(SEK) 
ICBT 
n=40 
TAU 
n=33 
p-
value 
GP visits 333 782 1,098 0.15 
Therapist, ICB support 
therapist and nurse 
Varies 856 2,198 0.002 
Phone counselling (15 min)  115 1,025 699 0.007 
Medication 
(antidepressants+sedatives) 
Varies 382 440 0.19 
ICBT program 1,000 1,000 . . 
Mean health care cost per 
patient  
(SD) 
 
4,044  
(1,853) 
4,434  
(2,651) 
0.73 
Time cost (treatment + 
transportation) 
Varies 1,598 1,421 0.39 
Sick-leave Varies 41,997 44,321 0.90 
Transportation  Varies 39 167 0.001 
Mean non-health care cost 
per patient  
(SD) 
 43,634  
(77,394) 
45,909 
(85,951) 
0.86 
Mean total cost per patient  
(SD) 
 
47,679  
(77,641) 
50,343  
(87,176) 
0.85 
GP, general practitioner; ICBT, internet-mediated cognitive behavioural therapy; SEK, Swedish 
kronor (1 SEK ~€0.105). TAU, treatment as usual. 
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Cost-effectiveness  
The main cost-effectiveness results are shown in Table 5. From a societal 
perspective (i.e. including all cost items), the cost per QALY with ICBT 
compared to TAU was 53,874 SEK, and the cost per reduced BDI-II score was 
3,896 SEK.  
As both the incremental cost and the incremental health outcome for ICBT vs 
TAU was negative (ICBT was less expensive and less beneficial) and thus 
ended up in the SW quadrant of the cost-effectiveness plane, the ICERs were 
positive (divided negative numbers give positive quota), which could be 
deceptively interpreted as ICBT being both more expensive and more effective 
(the NE quadrant of the cost-effectiveness plane) than TAU. However, in this 
case the result represented cost savings of 53,874 SEK per lost QALY and 
3,896 SEK per increased BDI-II score.  
From a health-care perspective, the results were relatively similar with savings 
per lost QALY of 5,371 SEK and a saving per increased BDI-II score at 388 
SEK. 
Table 5 also shows the results from the deterministic sensitivity analyses 
(scenario analyses). There is no substantial impact on the results, as the ICERs 
are all in the SW quadrant of savings per lost health, except for the scenario of 
no adjustment being made for the EQ-5D-3L difference at baseline. This result 
ends up in the dominant SE quadrant but, given its large variation, does not 
merit any further interpretation. 
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Table 5. Cost-effectiveness results of ICBT vs TAU. Costs per BDI-II 
point reduction and cost per QUALY. 
Scenario Cost per QALY Cost per BDI-II point 
Main estimates (ICBT vs TAU) 
Societal perspective 53,874 SEK* 
 
3,896 SEK* 
 
Health care perspective 5,371 SEK*  
 
388 SEK* 
 
Sensitivity analyses (ICBT vs TAU from a societal perspective) 
With non-commercial 
ICBT program (i.e. 
freeware) 
38,117 SEK* 
 
2,756 SEK* 
 
With multiple imputations 
for missing data 
17,245 SEK* 
 
1,247 SEK* 
 
Without adjusting for 
baseline differences in 
health 
 
118,753 SEK* 
 
ICBT dominant  
______________________________________________________________________ 
*Results indicate savings per lost QALY (BDI-II point) since ICBT was less expensive but also 
with less beneficial health outcomes. The 95% confidence interval was not defined because it 
included estimates in all four cost-effectiveness plane quadrants (and is thus not shown). Main 
estimates were based on QALYs and BDI-II changes adjusted for differences in baseline health 
status. 
BDI-II, Beck depression inventory-II; ICBT, internet-mediated cognitive behavioural therapy; 
QALY, quality-adjusted life year; SEK, Swedish kronor (1 SEK ~€0.105). TAU, treatment as 
usual. 
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Figure 6. Cost-effectiveness plane of ICBT vs TAU based on 1,000 bootstrap 
replications. 
The percentage number in each quadrant identifies the proportion of replications 
obtained in the respective quadrant. 
ICBT, internet-mediated cognitive behavioural therapy; QALY, quality-adjusted 
life year. 
 
Reproduced with permission from BMJ Open: Holst A, Björkelund C, Metsini A, Madsen JH, Hange D, Petersson EL, 
Eriksson MC, Kivi M, Andersson PA, Svensson M. Cost-effectiveness analysis of internet-mediated cognitive behavioural 
therapy for depression in the primary care setting: results based on a controlled trial. BMJ Open 2018;8(6):e019716. 
 
The 1,000 bootstrapped ICER replications were scattered throughout all four 
quadrants of the cost-effectiveness plane (33.5% in the NW (dominated), 
17.5% in the SE, 11.9% in the NE and 37.1% in the SW (dominant)) indicating 
uncertainty. See Figure 6.  
Therefore NMB was calculated for a range of assumed WTP threshold values 
per QALY together with a 95% confidence interval (CI). The 95% CI, 
irrespective of the value per QALY, included both positive and negative NMB 
estimates showing no clear results. See Figure 7. 
To sum up, we could show no evidence that ICBT was more or less cost-
effective than TAU, because costs, health outcomes and cost-effectiveness 
were similar for ICBT and TAU, from health care and societal perspectives. 
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Figure 7. Net Monetary Benefit (NMB) of ICBT vs TAU with 95% confidence 
intervals.  
Note: The NMB is shown for a range of assumed values for the willingness to pay per 
QALY (0 to 1.5 million SEK). 
QALY, quality-adjusted life year; SEK, Swedish kronor (1 SEK ~€0.105). TAU, 
treatment as usual. 
 
Reproduced with permission from BMJ Open: Holst A, Björkelund C, Metsini A, Madsen JH, Hange D, Petersson EL, Eriksson 
MC, Kivi M, Andersson PA, Svensson M. Cost-effectiveness analysis of internet-mediated cognitive behavioural therapy for 
depression in the primary care setting: results based on a controlled trial. BMJ Open 2018;8(6):e019716. 
 
Paper II – Patient experiences of ICBT 
Thirteen patients that received ICBT in PRIM-NET participated in the study. 
The sample was considered to be acceptably diversified in age, educational 
level and gender. However, a primary prerequisite for inclusion in the PRIM-
NET trial was that the patient be positive to ICBT. Additional criteria excluded 
patients without sufficient knowledge of the Swedish language or computer 
skills. As the patients were asked to describe their experiences of ICBT, it was 
not entirely clear whether their experiences reflected the internet- or the CBT-
part of ICBT. We conducted one focus group discussion with four patients and 
one with two patients. The latter was planned to include four patients but two 
of them cancelled right before the set appointment. However, the two 
remaining were eloquent and supported each other in sharing their experiences 
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freely and richly. Seven patients were individually interviewed. Detailed data 
on the patients are presented in Table 6.  
Table 6. Characteristics of the study subjects. 
Patient  Gender Age F/I* Working status Education 
1 F 27 I employed secondary school 
2 M 40 I employed university 
3 F 42 I employed university 
4 F 47 I employed university 
5 M 58 I employed university 
6 M 30 I - secondary school 
7 F 28 I employed secondary school 
8 F 43 F employed university 
9 M 45 F employed secondary school 
10 M 37 F employed university 
11 M 37 F employed university 
12 F 68 F other - 
13 F 31 F employed primary school 
*F,Focus group; I,individual interview 
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The patients were generous about sharing their experiences. Some described a 
need for face-to-face meetings with a psychotherapist and valued the check-
ups and the support during the ICBT process. Some felt left alone in the 
treatment while others felt well and secure. The possibility of privacy and 
freedom with smoothly working technology was valued, but there was also a 
lack of confidence and a feeling of risk. The findings are presented as a word-
cloud representing the most used words of the interviews (Figure 8), 
descriptions and concepts illustrated with selected quotations. 
   
Figure 8. Word-cloud representing the most used words of the interviews. By Anna 
Holst, 2018. 
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Privacy and well-functioning technology  
Most patients did not want it to be obvious that they suffered from – and got 
treated for – depression, as they were ashamed. They needed time alone at 
home to be able to do the ICBT, and that could be difficult to obtain. Others 
were open about their condition, and some even completed the ICBT during 
working hours. Most considered the Internet to be safe regarding their 
integrity. Most patients had some kind of technical problem with either the 
hardware or software. For others the technology worked smoothly, and this 
was important because depression involves low tolerance for adversity. 
ʻIt was a bit difficult in practical terms, in that I did not want the whole world 
to know that I was on ICBT for depression.ʼ 
With freedom comes responsibility 
ICBT was perceived as accessible and effective. The ICBT program was easy 
to access from their personal computer and they could choose when, to which 
extent and where to do the ICBT, such as at moments of alertness or outdoors. 
Some experienced difficulties finding suitable conditions to do the ICBT 
considering the location of the computer. Many experienced freedom and 
relaxation about not having scheduled appointments. Many patients felt 
stressed by the ICBT requiring too much from them. The perceived 
responsibility was too heavy for the progress of the treatment. Maintaining 
discipline could be difficult, and it was sometimes easier to avoid than to tackle 
the tasks. Some thought the tempo was too high to allow adaption to the new 
knowledge. On the other hand, some perceived the self-responsibility 
stimulating, since it signified the ability to influence one’s own health. The 
ICBT was experienced as meaningful and as an easy way to get into a better 
mood. 
ʻIt felt like it was very, very smart to have it on the Internet. It is fast; it is easily 
accessible. You can get immediate help just when you feel like it. Just turn on 
the computer and go into the different exercises.ʼ  
ʻI had a hard time, those days I felt bad, getting myself to sit at the computer 
and start.ʼ  
Inter-process feedback 
The regular contact with the psychotherapist was considered positive. The 
impaired ability caused by the depression meant that they needed someone 
pushing them to continue the ICBT treatment. Some considered the contacts 
stressful and felt guilty or controlled upon being contacted.   
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ʻI got a bad conscience because I felt I betrayed her when I did not do what 
she asked me to do.ʼ  
Some patients perceived the contacts with the psychotherapist as an 
opportunity for venting and support; some felt they covered only technical 
problems and practical issues. Sometimes the contact was too sporadic and 
came to nothing as time passed. Most patients would have appreciated a more 
comprehensive introduction to – and evaluation during – the ICBT. They also 
wanted continuity during the process and a closing meeting. 
ʻI had a therapist who called me and checked how I had proceeded and pushed 
me a bit and said, Come on, go through this chapter by tomorrow. I’ll call you 
back then. I needed someone to push me because I had a problem sitting down 
and getting things done, pursuing things…ʼ   
Does it work without the face-to-face meeting? 
Some patients appreciated ICBT and would have felt uncomfortable talking to 
a stranger in an unfamiliar place. They thought that writing down thoughts by 
the computer was a good alternative to a personal relationship. However, most 
informants missed the regular contact with a psychotherapist. They would have 
preferred to have the opportunity to speak out and dwell on experiences with 
someone listening.   
ʻYou can easily fool your computer. You get no eye contact, no body contact, 
you get no pat on the back.ʼ  
Many wished for real-time interaction with the psychotherapist for instant 
feedback and thus a possibility to make progress. Patients felt there was a large 
workload placed on the individual in ICBT treatment. Guidance and 
interpretation assistance were needed and a prerequisite for the treatment to 
work.  
ʻWhy do you do such a thing, replace the psychotherapist with software?ʼ  
Is ICBT a suitable treatment? 
ICBT can be an effective treatment for the right patients. However, since 
determination is needed to pursue the ICBT process, ICBT is not suitable for 
deeply depressed patients. The patients need to feel confidence in the choice 
of ICBT. Some perceived ICBT as a superficial tool. Some felt offended by 
being offered ICBT, in that it had been a big step for them to seek health care, 
and when they finally did, they were offered a self-help treatment. The 
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perception of not being taken seriously led to low confidence in the ICBT. 
Some feared they might crash mentally on ICBT, without healthcare noticing. 
ʻI think it may well have suited a great number of people, but not people like 
me, who dig down into their own thoughts and can’t come out of it.ʼ  
ʻI strongly believe in this, and I definitely think this is a good option.ʼ  
ʻHow dare they do this? They do not know how bad I feel. I could have thrown 
this book on the table and said, Damn health care, to hell with this!ʼ  
 
 
 
 
Paper III – Cost-effectiveness of collaborative care with a 
care manager vs CAU 
The baseline characteristics of the 376 patients constituting the primary sample 
of PRIM-CARE (41) are shown in Table 7. There were no statistically 
significant differences between the groups. 
Data on HRQoL and depression scores were available for 342 patients at 
baseline and at least one follow-up assessment. Analysing the 34 patients that 
dropped out just after randomisation showed that the only significant predictor 
was age (increasing in age by one year increased probability of missing by 
0.4%). Analysis of cost-effectiveness was based on this sample. 
Health outcome 
The CCCM group had better health outcome at the six-month follow-up than 
the CAU group in terms of both QALYs (0.357 vs 0.333) and DFDs (79.43 vs 
61.14). Both differences reached statistical significance (p<0.001).  
Cost outcome 
A detailed overview of identification, valuation, and distribution of costs is 
presented in Table 8. All costs are expressed at the 2016 price level. No patients 
were referred to psychiatric care during the 6 months observation time in the 
intervention or in the control group.   
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Table 7. Baseline characteristics of the PRIM-CARE patients.  
 
CCCM 
n = 192 
CAU 
n = 184 
Total 
n = 376 
Age, mean (SD) 40.8 (15.0) 41.6 (15.4) 41.2 (15.2) 
Gender, n(%) 
Women 
Men 
 
131 (68.2) 
61 (31.8) 
 
137 (74.5) 
47 (25.5) 
 
268 (71.3) 
108 (28.7) 
Occupation, n(%) 
Working 
Studying 
In search of work/other 
 
137 (72.9) 
18 (9.6) 
23 (17.6) 
 
122 (66.3) 
19 (10.3) 
43 (23.4) 
 
259 (69.6) 
37 (9.9) 
76 (20.5) 
Working, n(%) 
Full-time 
Other (25%-75%) 
 
157 (87.7) 
22 (12.3) 
 
149 (87.6) 
21 (12.4) 
 
306 (87.7) 
43 (12.3) 
Marital status, n(%) 
Cohabiting 
Single 
 
122 (67) 
61 (33) 
 
122 (68) 
58 (32) 
 
244 (67) 
119 (33) 
Born outside of Nordic 
country, n(%) 
18 (9.4) 21 (11.5) 39 (10.4) 
Educational level, n(%) 
Primary education 
Secondary education 
University 
 
17 (8.9) 
103 (53.9) 
71 (37.2) 
 
27 (14.8) 
90 (49.2) 
66 (36.1) 
 
44 (11.8) 
193 (51.9) 
137 (36.6) 
Sick-leave at baseline, n(%) 93 (50.5) 94 (55.0) 187 (52.7) 
MADRS-S  m(SD) 20.8 (7.2) 21.9 (7.1) 21.4 (7.1) 
BDI-II  m(SD) 23.9 (8.7) 25.1 (8.5) 24.5 (8.7) 
EQ-5D  m(SD) 0.58 (0.24) 0.56 (0.25) 0.57 (0.24) 
BDI-II, Beck Depression Inventory II; CAU, care as usual; CCCM, collaborative care with a 
care manager; EQ-5D, EuroQoL five-dimension; MADRS-S, Montgomery-Åsberg Depression 
Rating Scale-Self rating version  
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Table 8. Cost items, volumes used, costs per unit and average cost per 
patient. 
Cost item Volume          Cost/unit (SEK)    Cost/patient 
(SEK) 
 
CCC
M 
CAU CCCM CAU CCCM CAU 
Education physicians  
(per physician) 
11 - 7,747.00 - 443.84 - 
Education nurses 
(per nurse) 
11 - 8,287.00 - 474.78 - 
Nurse contacts  
(face to face) 
384 203 103.59 103.59 207.18 114.28 
Physician contacts  
(face to face) 
447 413 363.14 363.14 845.44 815.09 
Psychologist contacts 
(face to face) 
370 421 262.97 262.97 506.77 601.69 
Physiotherapist 
contacts (face to face) 
29 79 145.23 145.23 21.94 62.36 
Nurse contacts 
(phone) 
1513 417 51.79 51.79 408.15 117.38 
Physician contacts 
(phone) 
298 284 121.05 121.05 187.87 186.83 
Psychologist contacts 
(phone) 
39 41 60.69 60.69 12.33 13.52 
Medication - - - - 566.05 552.62 
Total health care 
costs 
- - - - 3,674 2,464 
Sick-leave (days) 5,756 7,076 1,824 1,824 58,500 71,241 
Total costs 
- - - - 
62,174 73,705 
CCCM, collaborative care with a care manager; CAU, care as usual; SEK, Swedish kronor (1 
SEK~ €0.1).  
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The distribution of health care costs was rather similar among groups. The 
greatest share of healthcare costs was related to contacts with healthcare 
professionals in both groups. Obvious differences were observed in visits to 
and phone contacts with the nurse (depending on the nature of the intervention) 
and education costs, which were likewise only related to the care manager 
programme. The difference in mean costs between the two groups was not 
statistically significant. 
 
Cost-effectiveness  
The main cost-effectiveness results are shown in Table 9. From a societal 
perspective, CCCM dominated CAU (SE quadrant), in that it produced larger 
health benefits at a lower cost. From a health care perspective, the cost per 
QALY was 67,731 SEK and the cost per depression free day was 71 SEK (NE 
quadrant). 
 
Table 9. Cost-effectiveness results of CCCM vs CAU. Costs per QALY 
and DFD. 
Incremental cost-effectiveness ratios cost-effectiveness  
Cost per QALY: Societal perspective  
Cost per QALY: Health care perspective 
Care manager is dominant 
67,731 SEK 
 
 
Cost per DFD: Societal perspective Care manager is dominant  
Cost per DFD: Health care perspective 71 SEK   
CCCM, collaborative care with a care manager; CAU, care as usual; QALY, quality-adjusted 
life year; DFD, depression-free day; SEK, Swedish kronor (1 SEK~ €0.1). 
 
Most of the bootstrapped ICERs ended up in the SE quadrant of the cost-
effectiveness plane (dominant), indicating that CCCM is likely to be more 
effective and less costly than CAU. From a health care perspective, most 
ICERs were in the NE quadrant, indicating that CCCM increases costs but 
improves health. See Figure 9. 
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Figure 9. Cost-effectiveness planes with confidence ellipses. Left graph: societal 
perspective, right graph: health-care perspective. CAU, care as usual; QALYs, 
quality-adjusted life years. 
 
Figure 10. Cost-effectiveness acceptability curves for various willingness-to-pay 
thresholds for one quality-adjusted life year gained based on health-care and 
societal perspectives. 
Figure 8 and 9 reproduced with permission from BMJ Open: Holst A, Ginter A, Björkelund C, Hange D, Petersson EL, 
Svenningsson I, Westman J, André M, Wikberg C, Wallin L, Möller C, Svensson M. Cost-effectiveness of a care manager 
collaborative care programme for patients with depression in primary care: economic evaluation of a pragmatic randomised 
controlled study.  BMJ Open 2018;8:e024741. 
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The probability of CCCM being cost-effective for several WTP threshold 
values per QALY is shown in Figure 10. At a WTP threshold value of €10,000 
(100,000 SEK) per QALY, there was a 93% probability of CCCM being cost-
effective from a societal perspective and a 97% probability from a health care 
perspective (higher as a result of less variability). 
To sum up, CCCM was highly cost-effective compared to CAU, particularly 
from the societal perspective, but also from a health care perspective. 
 
 
 
 
 
Paper IV – Director and clinician experiences of collaborative 
care with a care manager 
Of 83 PCCs with established care manager, 39 were included based on 
strategic sampling. Three declined participation. The remaining 36 PCCs 
employed 937 clinicians and 36 directors, all of which were sent an email 
containing a questionnaire and information.  
Of a total of 784 clinicians, 465 consented to participation by submitting the 
questionnaire, and four were excluded, as they were no longer employed at the 
included PCCs. Finally, a total of 461 clinicians (59%) were included in the 
analysis. 
The email to directors reached 36 directors, and all of them consented to 
participation by submitting the questionnaire, yielding a total of 36 directors 
included in the analysis (100%).  
For both groups (clinicians and directors), 50% of the respondents were in the 
age range of 31-50 years, 86% were female and 70%-75% had a public 
employer. The most common profession was nurse followed by physician. The 
most common PCC size was >24 employees and the most common 
geographical location was urban.  
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Quantitative results 
Clinician perceptions of the care manager implementation 
Of the clinicians, around 10% were not at all familiar with the care manager’s 
assignments and responded ʻ no opinionʼ to the other items of the questionnaire 
in 70%-95% of the cases. Most of them were administrative staff rather than 
care providers.  
Fifty-two per cent of clinicians had the opportunity to cooperate with the care 
manager without problems. The majority were doubtful (neither agreed nor 
disagreed) whether they had received information about the care manager’s 
assignment and 40% judged their knowledge of it as insufficient. However, 
56% perceived that work routines for the care manager existed at their PCC. 
Approximately half of the clinicians reported their patients being generally 
positive to the care manager's efforts. Around two thirds thought that 
collaborating with the care manager was part of their duty as PCC staff. 
Clinician perceptions of barriers and facilitating factors in 
cooperating with the care manager. 
Forty per cent of the respondents prioritised working with the care manager. 
Around half of them perceived that the assignment of the care manager 
corresponded to the aims of the PCC, 42% perceived support from colleagues 
and 51% perceived support from their directors in collaborating with the care 
manager. Around 50% did not perceive conflicts with existing routines or 
uncertainties in the assignment of the care manager, and ~40% did not perceive 
any unclear division of responsibilities between the respondent as a clinician 
and the care manager. Most of the respondents had been informed about the 
care manager. 
Most respondents reported that they were used to working with new methods 
and only ~10% perceived that it was difficult to make use of the care 
management.  
PCC director perceptions of the care manager implementation  
Almost 90% of the PCC directors considered that the assignment of the care 
manager had been clearly designed, ~70% considered the priority of the 
implementation to be high, and ~90% were positive to the implementation. 
More than half of the directors – more often at smaller than at larger PCCs – 
had reorganised in conjunction with the care manager implementation. 
Clinicians’ attitudes to the implementation were rated as positive by most 
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directors, but the proportion of positive ratings was greater at small and urban 
PCCs than at large, city or rural PCCs. 
In cases not mentioned above, the results showed no clear differences in terms 
of type of profession, size or geographical location of the PCC. 
Qualitative results 
Thirty-six directors and 135 clinicians answered the open-ended questions. 
The answering clinicians’ professions were in the majority physician or nurse. 
Overall, the responses were short and concise, and as the responses from the 
directors and the clinicians did not differ in any essential way, they were 
analysed together in one group. The analysis resulted in the following 
categories:  
Organisational changes – resourceful well-ordered caring 
The implementation of a care manager was perceived positively by PCC 
directors and clinicians especially at PCCs lacking resources in the 
psychosocial area. The implementation had resulted in a clear organisation for 
patients with mental illness, and the directors experienced results of improved 
utilization of the PCCs resources. Organisational changes made at the PCCs to 
implement a care manager, such as forming psychosocial teams, provided 
opportunities to raise important issues and increased the interest in patients 
with mental illness. However, at PCCs with good access to psychosocial 
resources, the perception was that a care manager did not add anything further.  
The size of the PCC could facilitate or hinder the possibility of getting in touch 
with the care manager. At smaller PCCs, the contact was facilitated by patients 
having easy access to the care manager. The implementation of a care manager, 
with its structured approach and designated time together with frequent and 
active contacts with the patients, led to new routines with early assessment 
resulting in improved patient flow. According to the clinicians, the care 
manager provided support in the medical follow-ups of patients. As a 
consequence, clinicians perceived themselves to be less isolated when giving 
care, and the patients received closer follow-ups.  
Barriers – the art of finding the time in a tight work situation 
It took time for the role of the care manger to be incorporated at the PCC, 
leaving the clinicians with a feeling of insufficient knowledge about the care 
manager function. Some concerns were raised that the high workload, lack of 
time for cooperation or the care manager being absent from the PCC could lead 
to the care manager position not being used as intended. This could result in 
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the care manager falling from awareness. Many concurrent demands and tasks 
at the PCC affected the ability to implement the care manager position.  
Facilitators – soft values and structured roll-out 
For collaborative care with a care manager to work, a good collaborative 
climate among the director and the clinicians at the PCC was crucial, and it 
was important to have a positive attitude towards new challenges. Personal 
characteristics of the care manager were valued as important, such as a 
willingness to interact with the other clinicians at the PCC, and an explicit 
interest in mental health.  
The directors stated that financial compensation was crucial to be able to 
allocate resources for the implementation of the care manager. Directors also 
valued participating in part of the academic education of the care manager as 
the course was helpful towards implementation. The support from the 
implementation team was also valued.  
  
Aspects of cost-effectiveness and feasibility of primary care implementations 
58 
 
It’s all about the location                                                                                                Photo: Ken Mattison 
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Discussion 
Major findings 
The PRIM-NET trial compared ICBT to TAU, and the PRIM-CARE trial 
compared CCCM to CAU as treatment and care for mild to moderate 
depression in Swedish primary care. Cost-effectiveness and how the 
intervention was experienced by patients and health care staff are important 
perspectives in the effectiveness approach, which should shed light on as many 
important aspects as possible, to increase the likelihood of creating value in the 
complex system of the real world (24).  
 
ICBT is an acceptable and feasible treatment for depression 
Our results suggested that ICBT is an acceptable alternative for treating 
depression from the perspectives of patient experience and cost-effectiveness. 
No firm conclusions could be drawn from our results as to whether ICBT or 
TAU was the most cost-effective use of health-care and societal resources. 
There was a great deal of uncertainty, as illustrated by the ICERs scattered over 
all the four quadrants of the cost-effectiveness plane. The mean cost per patient 
in our sample was modestly lower for ICBT than for TAU both from health 
care and societal perspectives, but the differences were not statistically 
significant. Even though the TAU group on average spent more on health care 
personnel resources, the cost of the ICBT software was significant. The largest 
cost in both groups was productivity loss related to sick leave. The health 
benefits measured as QALYs and reduction in BDI-II score were comparable 
for ICBT and TAU. Patient experience of ICBT pointed in the same direction, 
as the findings described ICBT as a good alternative to common depression 
treatment; however, the patients presented diverse experiences. Some patients 
appreciated the possibility of getting treatment without having to repeatedly 
meet with health personnel in real time, but many patients expressed a need for 
face-to-face contact with a psychotherapist and valued real-time interaction, 
human contact, guidance and dialogue. Many patients felt that healthcare 
placed a heavy responsibility on their shoulders by sending them away with 
ICBT, and some expressed indignation at being treated as one in a pile of 
depressed patients. However, all of the patients appreciated the freedom of 
being able to work with ICBT anytime, anywhere and to an extent they chose. 
This freedom may be a great advantage considering that most patients with 
depression are working and need the possibility of choosing when to have 
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treatment so as not to affect their work. They also stressed the importance of 
easily used and highly functioning technology.  
 
Collaborative care with a care manager is an effective way of giving 
care for depression 
CCCM was shown to be an effective way of providing care for depression from 
the perspectives of cost-effectiveness and PCC directors’ and clinicians’ 
experiences. The health benefits were significantly greater statistically in 
CCCM than CAU in terms of QALYs and DFDs. The mean health care cost 
per patient was modestly higher for CCCM than for CAU which was explained 
by the nature of the care manager programme. The mean total cost per patient 
was higher in CAU but with no statistical significance. From a societal 
perspective CCCM dominated CAU in that CCCM was both cheaper and more 
beneficial. From a health care perspective CCCM was cost-effective already at 
a modest willingness to pay per QALY (97% likelihood of cost-effectiveness 
at a WTP per QALY of 100,000 SEK).  
The findings of the PCC directors’ and clinicians’ experiences of 
implementing and working within CCCM pointed in the same direction. We 
divided the results by size and geographical location of the PCC, but in most 
of the areas studied there were no important differences between the groups. 
Most of the clinicians reported that they had routines for the work in CCCM at 
their PCC and that they had support from colleagues and directors. The PCC 
directors were generally positive to the implementation of CCCM and rated 
their clinicians’ attitudes towards the implementation as positive, to a greater 
extent at small and urban PCCs, than at large, city or rural PCCs. Most PCCs 
had reorganised working routines and educated existing staff in conjunction 
with the implementation. Regarding successful implementation the directors 
highlighted the overall positive attitudes of clinicians interacting with the care 
manager, and that CCCM be enhanced by guidelines and education. Important 
facilitators for the implementation of – and collaboration within – CCCM were 
support from colleagues and directors, cooperative skills and positive attitudes 
of clinicians. Barriers were high workload, shortage of staff and extensive 
requirements and demands from the health care organisation. 
PRIM-CARE is one of the reports on implementing a care manager for 
depression treatment in primary care, in which the formation of collaborative 
care is generated within the primary care context and at the PCC, with the care 
manager as one of the ordinary personnel and working together with the PCC 
team (136). 
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General discussion 
Differences in study design and health-care systems, including aspects such as 
professional roles, resources, access to health care or organisational levels of 
care, limited the comparison of patient and staff experience as well as costs, 
benefits and cost-effectiveness studies.  
 
Cost-effectiveness of CCCM och ICBT 
The evaluation of interventions that can facilitate the implementation of 
evidence-based care for patients with depression in primary care is of great 
importance, as there are identified knowledge gaps in this area (59, 75). It is 
crucial to assess the cost-effectiveness of an intervention, because societal and 
health care resources are limited, and decision makers need thorough 
documentation to be able to prioritise between the different options.  
To assess the costs and benefits that are relevant to identify and measure in a 
study, clinical experts with knowledge of the medical conditions and resources 
that may be involved should cooperate with health economists who can 
identify what constitutes real resource consumption and what does not (e.g. 
transfers of resources from one point to another within the same system should 
not be characterized as costs). In both of our cost-effectiveness studies (Papers 
I and III) experts on both health economics and the regular clinics of primary 
care collaborated closely. 
Several studies have suggested that ICBT is a cost-effective treatment option 
for depression (76-79), but until now (Paper I), no ICBT cost-effectiveness 
study had been conducted in the Swedish primary care context. McCrone et al. 
found that ICBT was more effective than TAU in UK primary care at a minimal 
additional cost and that reductions in levels of sick leave were greater in ICBT 
than TAU, but that study was not restricted to patients with depression (76). In 
the REEACT trial, also conducted in UK primary care, the cost-effectiveness 
analysis suggested that none of the ICBT programs studied were cost-effective 
compared with usual GP care alone (80). However, comparisons with our 
results should be made with caution, as study design, follow-up and 
methodology differ.  
The cost-effectiveness study of CCCM was the first such study conducted in 
the Swedish primary care context (Paper III), and our results were in line with 
the majority of existing literature (92, 94, 97) showing CCCM to be cost-
effective. The systematic review of Gilbody et al. showed that the majority of 
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the included economic evaluations from the US found positive health effects 
as well as increased health care costs associated with the intervention. ICERs 
were located in the NE quadrant of the cost-effectiveness plane, indicating that 
the intervention was more effective and more costly than CAU. However, none 
of the reviewed studies had included societal costs. Gilbody et al. noted that a 
societal perspective is more meaningful to policy makers and that there is 
evidence of collaborative care programmes having positive effects on sick 
leave (98). In our study, 70% of the population were in the work force, 
indicating that a societal perspective was of high relevance for this study. A 
recent systematic review showed CCCM being dominant, meaning that 
intervention was more effective and less costly. However, only five out of 
nineteen studies had used a societal perspective (137), making direct 
comparisons impossible. More recent evaluations have accounted for societal 
costs and are therefore more suitable for comparison. Aragonès et al. found in 
Spain that the collaborative care programme INDI was cost-effective. 
Nonetheless, the small differences in sick-leave days between the study groups 
kept the total costs in the intervention group higher than in the control group. 
This located the ICER in the NE quadrant of the cost-effectiveness plane (138). 
The results of a German study were similar to ours in that the total costs of the 
control group exceeded the total costs of the intervention group, when societal 
costs were included. However, our results were more favourable for CCCM 
mainly because of lower costs in nearly all cost categories. Effects regarding 
QALYs were almost identical to our study (139). Both of the studies identified, 
as we did, societal costs as the largest share of total costs.  
 
Productivity loss may be underestimated 
Productivity loss is the largest societal cost for depression (76), and 
absenteeism (i.e. sick leave) is the most common outcome measure. People 
with depression usually go to work, but their condition can substantially reduce 
their performance. This is known as presenteeism (140). Eighty-one per cent 
of the costs of lost productivity could be explained by reduced performance 
while at work during depression according to Stewart et al. (140). Most studies 
do not take into account presenteeism; thus, the costs of productivity loss 
during depression may be far higher than is commonly estimated and small 
improvements in depressive symptoms may have a great bearing on those 
costs. In future studies of the cost-effectiveness of treatments of depression, 
presenteeism would be an important factor to take into account. 
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Age and personality traits may matter, and depressive symptoms 
certainly do 
In our study (Paper II), some patients experienced ICBT a heavy responsibility 
for their own recovery, and they could not maintain the discipline needed to 
carry out the treatment. Depression is known to affect motivation and 
executive abilities (68), which may partially explain these experiences. 
Wilhelmsen et al. showed that patient motivation to persist in ICBT is crucial 
to its completion and that motivation is closely linked to a feeling of 
relatedness which is enhanced by a social relationship with the therapist, 
suggesting that face-to-face support during ICBT is preferred (141). The age 
range in our study was 27 - 68 years. In one study, depressed elderly patients 
were suggested to be unsuitable for ICBT as they might lack skills to use web-
based resources and computers (142). However, Karyotaki et al. showed that 
elderly people were more likely to respond to ICBT than younger ones (70). 
Many patients perceived themselves as too ill to benefit from ICBT, even 
though none had a more severe degree of depression than moderate according 
to MADRS-S (43). Patients also expressed a feeling that, in ICBT, they were 
left unguarded by health care compared to those treated by face-to-face therapy 
and that this could be hazardous for deeply depressed patients. However, a 
recent meta-analysis of self-guided ICBT showed that ICBT patients were less 
likely to deteriorate than the control group, and that ICBT cannot be judged as 
harmful (143). 
Personality traits of the patients were not investigated in our ICBT studies 
(Papers I and II). A study by Bendelin et al. of advertisement-recruited 
patients’ experiences of ICBT showed that ICBT was perceived in different 
ways depending on personality traits. Patients with a practical hands-on 
approach were more positive towards ICBT than those with more of an 
uncertain and doubtful personality (122). However, this phenomenon has been 
observed even in face-to-face CBT. Further studies of ICBT for depression 
could benefit from analysing potential differences in effect, costs and 
experiences for different personality profiles or other differences that may exist 
between groups of individuals. For CCCM a focus group study of patient 
experiences is under way. 
 
The need for a helping hand 
Since depression is known to affect executive abilities and tolerance for 
adversities, the need is great for support and guidance – in the health-care 
system and in treatment – as are the well-known factors of continuity and 
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accessibility. In our study (Paper II) feedback and help from the therapist 
during ICBT was appreciated by the patients, particularly as support and a push 
when needed, but as they had only met the therapist once at the start of the 
treatment, they perceived the feedback as not deep and personal enough. To 
make patients feel secure and not left alone seems to be important (144). Care 
managers, in a recent study of their experiences of CCCM felt they constituted 
a safety net for patients by following and supporting them. This increased 
continuity and accessibility to primary care for patients with depression (145). 
 
Cyberspace and hardware considerations 
Some patients believed that the feedback process in our ICBT study (Paper II) 
would have been more helpful in a real time chat- design rather than email; the 
immediate response seemed important. This ICBT mode has been successfully 
tested (126), but requires as much therapist time as face-to-face therapy. Well-
functioning and accessible technology seems to be crucial, and both hardware 
and software options could be developed to make ICBT even more feasible. 
Bargh et al. (146) found that some people feel more able to express their true 
selves on the Internet than in face-to-face interaction. In our results we found 
few such opinions, but some patients valued getting treatment without talking 
to a person they were not familiar with. The opportunity ICBT offers of getting 
treatment in privacy, and the freedom of being able to choose a time and place 
for treatment, was stressed as positive. No one worried about online integrity.  
 
Blending care 
There is evidence that blending care, combining ICBT with face-to-face 
psychotherapist support, is more effective than ICBT without face-to-face 
support in community and secondary care (72, 83). In our study, many patients 
suggested that ICBT be a part of a therapeutic intervention. Some suggested 
that if CBT was initiated by face-to-face meetings to develop a relationship, 
ICBT treatment would be made more effective by the patient feeling more 
secure and individually treated. In line with this, psychotherapists of the PRIM-
NET trial considered ICBT as a good treatment that should be introduced to 
primary care. Several adaptations of ICBT were suggested to optimise the 
procedure in primary care settings. Integrating and blending ICBT and face-
to-face therapies, for example, would render primary care psychology more 
efficient (82).  
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Facilitators for implementing CCCM 
Our results from studying clinician and director experiences of CCCM 
implementation (Paper IV) are in broad agreement with previous studies (94, 
95, 97, 100-103). The care manager being on site at the PCC is seen as an asset 
facilitating collaboration with remaining staff (97, 100). Our and other studies 
highlight the importance of ensuring that the person employed for the care 
manager role is dedicated, and that the right training and support is supplied. 
Important facilitators are also the soft values of care managers and other staff; 
values such as cooperative skills and positive attitudes to the challenge (100, 
101). In the present study, no respondent highlighted the well-known benefit 
of a standardised systematic clinical pathway, which the care manager 
intervention represents (41, 95, 100). In one review it was concluded that 
implementation requires a buy in from commissioners to ensure financial 
barriers are removed and that allowing sufficient training for staff is essential 
both at the planning stage and in the long term (100). 
 
Barriers to implementing CCCM 
Our results of time constraints and high workload being critical factors when 
implementing collaborative care are in agreement with other studies (101, 
103). However, neither the barriers nor the facilitators identified are unique to 
collaborative care. A focus group study with care managers (145) showed that 
they perceived their function as helping to provide continuity – a main task of 
primary health care – and this enabled them to follow and support patients with 
depression and to maintain close contact during the illness. To provide a care 
manager from outside the ordinary PCC team as a collaborative care 
implementation, as described in a recent publication, does not seem to be as 
effective as CCCM in terms of constancy (103). 
The CCCM study (Papers III and IV) indicates that the implementation of 
CCCM for depression in primary care was partly successful. Still, important 
factors remain concerning information sharing, knowledge about care 
management, and financial, organisational, administrative and professional 
structures. All these factors must be continually attended to, both at the PCC 
and the regional management levels.  
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Methodological considerations – strengths and limitations 
Paper I  
The design of the PRIM-NET study was a strength. It is generally 
acknowledged that pragmatic effectiveness studies are the most informative 
for economic and cost-effectiveness conclusions (25). A major strength was 
that the patients were exclusively primary care patients. Additionally, patients 
with somatic co-morbidity were not excluded, making the study population 
representative of primary care patients, who often suffer from mental and 
somatic co-morbidity. Another strength was the diversity of age and gender 
within the included population; there was a higher proportion of men in the 
study population than in previous studies. Thoroughly scrutinised EPR for care 
consumption throughout the entire period of follow-up provided legitimacy of 
health-care cost outcomes. Average standard costs are listed for several posts, 
such as GP visits. However, these are not only marginal costs but also rental 
and overhead costs. We considered it was more accurate to calculate actual 
costs, because we had the possibility of thorough data collection of care 
consumption. 
We assessed cost-effectiveness for the period of twelve months from baseline. 
This captured most of the relevant consequences of the intervention. 
Discounting was not needed, as the time period did not exceed one year. 
Absenteeism and sick leave 
To get as complete data on absenteeism (140) as possible is central in cost-
effectiveness analyses of depression interventions, because productivity loss 
from absenteeism constitutes the largest part of societal costs. Due to the trial 
exclusion criteria, patients with high risk of secondary care needs were not 
included, and consequently no costs for hospital care were generated. Our data 
on absenteeism were collected by patient reports of days on sick leave, with no 
consideration given to part- or full time, which was a weakness. However, 
returning to work following an absence, seems to be a more important 
improvement than to progress from part-time to full-time work. Complete data 
collection of sick leave events is a major challenge since there is no solid 
method. Firstly, a patient report of sick leave is the most accurate data 
collection method as patients can be absent from work without informing 
health care or the Social Insurance Agency (Försäkringskassan); however this 
is insecure given the human tendency to not remember actual circumstances. 
Secondly, data from the Social Insurance Agency, the authority that is notified 
of sickness (apart from the patient’s employer), is not complete, because the 
two first weeks of sick pay are paid by the employer. Thirdly, the EPR of today 
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are not designed for data collection, so the EPR of every single patient needs 
to be explored to get sickness data.  
The lack of sick-leave data for some patients was a weakness. However, 
missing sick-leave data occurred in both ICBT and TAU populations and the 
difference in mean sick-leave costs between the two groups was small and 
possibly random. However, a sensitivity analysis was made of a scenario using 
multiple imputations for missing sick-leave data. The ICER was affected 
minutely and did not change the interpretation. 
The journey from RCT to controlled trial 
A major limitation was that, at the end of inclusion to the PRIM-NET trial, the 
randomisation process was hampered as follows. PRIM-NET was designed as 
an RCT in which all included patients were randomised to TAU or ICBT. 
However, there were difficulties in recruiting patients, as only patients 
attending primary care with a new depression and positive attitudes towards 
ICBT were recruited. Other studies with these difficulties have used 
advertisement or Internet recruitment, yet been unable to reach the calculated 
power (147). Therefore, eight patients randomised to TAU were transferred to 
the ICBT group at the end of the recruitment period to obtain a higher number 
of ICBT-treated individuals at the twelve-month follow-up. That is, PRIM-
NET can be categorised as an RCT only for the first three months of follow-
up. At the twelve-month follow-up we categorised it as a controlled study 
without randomisation. 
 
Paper II  
A key strength of this study was – as in Papers I, III and IV – that the patients 
were exclusively primary care patients. Only a few similar studies been 
conducted (126, 127), which is astounding considering the amount of studies 
on the clinical effectiveness of ICBT in similar contexts. This study is also one 
of few reporting negative consequences of ICBT (88). 
The study sample 
All ICBT patients from PRIM-NET (n=52) were invited to the study, and 
seventeen patients initially agreed to participate. The ones who did not, gave 
lack of time as their reason. Gradually four persons withdrew and, finally, 
thirteen patients were included. There was thus no strategic sampling 
procedure which may be a limitation. In all research it is up to the individual 
to participate or not, and this may cause bias. However, STC does not claim its 
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results as being generalizable, but rather exploratory (124). The number of 
patients was considered sufficient and the included patients were acceptably 
diversified in age and gender, enabling a broad description of ICBT 
experiences. There was relative homogeneity with regard to cultural 
background; informants were with one exception native Swedes. Also, for 
some of the patients, quite a lot of time had passed between their treatment and 
this study. To sum up, our results cannot be regarded as generalizable for all 
people receiving ICBT, or even for all participants in the PRIM-NET study. 
Focus groups and interviews 
A strength was that moderators and interviewers had different occupations 
(GP, occupational therapist and nurse), creating wide analytic space, which 
increased the validity of the results. Additionally, none of the 
moderators/interviewers had in any way been part of the patients’ ICBT 
treatment. Data were collected in neutral surroundings. The patients were very 
informative, had clear views of their experiences of ICBT, and presented them 
openly. Our impression was that they expressed themselves honestly and did 
not try to meet any expectations. One of the focus groups contained only two 
patients, which generally is too few to create a wide discussion, but since these 
two patients were very eloquent and helped each other to remember their 
experiences, the discussion became very informative. 
Analysing in cooperation 
Three of the authors cooperated in the analysis seeking to adhere strictly to the 
guidelines of the STC research method. Preconceptions were identified to the 
extent possible before conducting the focus groups, interviews and analysis. 
However, the risk of researcher bias, that is, a bracketing deficit affecting the 
results, could not be totally eliminated.   
Psychotherapist continuity 
Most patients had wished for a more comprehensive introduction to the ICBT 
from the psychotherapist; they lacked evaluation during ICBT and a closing 
meeting. Continuity was stressed by most informants as a very important 
factor. Circumstances of geography and lack of time meant that some patients 
were diagnosed and included in the PRIM-NET study by an external 
psychotherapist who was not the same one guiding the patients in their ICBT. 
This was a weakness, as it may have biased the results of these patients’ 
treatment effects as well as their experiences. However, the aim in standard 
ICBT is to maintain psychotherapist continuity. 
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Paper III  
This study has several strengths. Firstly, it is highly relevant both on a national 
health-care level and a societal level, as mental health problems today 
constitute a growing part of health-care costs, especially at the primary care 
level. Secondly, patient, care-consumption and sick-leave data obtained by 
examining EPR, in addition to patient and health-care personnel reports, were 
extensive. Thirdly, participation rates were robust for both PCCs (urban and 
rural scattered over the region with 10% of all PCCs participating) and patients 
(acceptably diversified in age and gender). The latter may partly have been a 
result of the support from the study group, which had thorough experience of 
primary care and accomplishing primary care clinical trials. Fourthly, we used 
both health-care costs as well as societal costs for our analyses, as societal costs 
widely exceed health-care costs in the form of sick-leave costs. Fifthly, 
randomisation was done at the PCC level instead of the patient level, because 
the intervention was supposed to imply a change in the PCC working system. 
This would have made it inappropriate to randomise at the patient level. 
Last but not least, we used robust and accepted methods of health economic 
analyses and modelling. Discounting did not have to be done as the time period 
was less than one year. The results of this trial could consequently be 
generalizable to and representative of Swedish primary care. 
What will happen around the corner? 
The short follow-up time of six months was a limitation. Health economic 
consequences of health-care consumption, health status and sick leave should 
preferably be assessed over a longer time perspective. However, we feel most 
of the relevant consequences of the intervention are covered within the first six 
months, mainly because the intervention lasted for only three months. A long-
term analysis of CCCM will be conducted shortly, as data from the twelve-
month follow-up become available. It is likely that CCCM would be even more 
cost-effective with a longer follow-up time, considering that improved health 
was maintained at six months.  
Absenteeism and sick leave 
As mentioned in the method discussion section of Paper I, it is central to get as 
complete data as possible on absenteeism in cost-effectiveness analyses of 
depression interventions, as productivity loss from absenteeism constitutes the 
largest part of societal costs. However, there is no solid method for this. In 
PRIM-CARE, our data on absenteeism were collected by patient reports of 
part-time and full-time sick days. We also collected data on sick days from 
EPR to assure the quality of patient reported data. This was a strength 
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compared to the method used in the PRIM-NET study. However, presenteeism 
was not assessed (140). Due to the trial exclusion criteria, patients with high 
risk of secondary care needs were not included, and consequently no costs for 
hospital care were generated. 
 
Paper IV  
The strengths of this study are several. Firstly, a major strength is that at 
baseline, a collaborative care organisation with a care manager was 
implemented at 83 PCCs making it possible to apply a strategic sampling of 
PCCs by geographical location, funding and PCC size. Secondly, when we 
conducted the study the implementation of care managers at the PCCs had been 
going on for at least a year, and the organisational changes had had time to 
adapt to the individual PCC and its staff. Thirdly, the use of previously used 
items in the questionnaires (129-131) was a strength. Fourthly, the 
participation rate of the clinicians was acceptable and outstanding for PCC 
directors. The opportunity of open answering may have facilitated addressing 
both important research questions concerning implementation as well as 
capturing the real world. This resulted in a broad understanding of the 
implementation process. However, some of the open answers were short and 
sometimes difficult to interpret.  
The questionnaires 
Another limitation would be the lack of validated questionnaires in this 
research area. However, most of the items in the clinician questionnaire were 
tested for reliability. The other items in the questionnaires were previously 
used (129-131). A weakness was that the open-ended questions were limited 
and the answers short. A focus group study with physicians will be presented 
in a separate publication (manuscript under preparation).  
No patients were included in the present study; however, patients’ experiences 
were studied and will be presented in another publication (manuscript 
submitted). 
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Implications for healthcare  
The high incidence of depression makes it important to evaluate and implement 
new evidence-based effective forms of treatment and care. Despite the high 
quality of medical and psychotherapeutic competence in Swedish primary 
care, cornerstones such as accessibility, coordination and continuity are not 
sufficient to meet the needs of patients with depression and anxiety. New forms 
of treatment and care should be evaluated not only in follow-ups, but also up-
stream or parallel to implementation, since interventions of disputable benefit 
should be avoided in observance of basic ethical principles. Studies on patient 
and staff experiences of interventions are scarce but very important from an 
effectiveness perspective. Both the PRIM-NET and PRIM-CARE trials are 
examples of pragmatic effectiveness research conducted in the real world, 
alongside implementation of ICBT and CCCM in Swedish primary health care. 
The knowledge gained from these studies is broad and representative and could 
preferably be used in decision making and prioritization in health care. 
ICBT as safe and effective treatment for depression in primary care has been 
widely introduced in recent years as a solution to the problem of accessibility 
to psychotherapy. However, our results on cost-effectiveness and patient 
experiences highlights that TAU should not be replaced by ICBT; rather, both 
options should be available. Although there may be positive effects for society, 
the patient’s preference must be ascertained in patient-centred consultation. 
PRIM-CARE shows that CCCM is beneficial to patients and for the national 
economic system. However, the major benefits are obtained on a societal level, 
while the costs for increasing quality of care and effectiveness are generated 
on the (primary) health care level. If Swedish authorities decide on a 
nationwide implementation of CCCM the financing of the implementation 
should include transforming the societal health insurance gain to the primary 
health care level. Also, implementation would benefit from a bottom-up 
perspective so that the introduction and development of CCCM at the PCC 
includes the PCC team as a whole to secure sufficient knowledge and 
adaptation.   
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Conclusion  
ICBT is a safe and effective treatment that seems to be an acceptable 
alternative to TAU for treating depression in Swedish primary care from the 
perspectives of the patient experience and cost-effectiveness. ICBT seems to 
be as cost-effective as TAU both from a health care and societal perspective. 
The largest cost is productivity loss related to sick leave. ICBT is an attractive 
alternative in primary care to some patients with depression, but not to all. The 
freedom of being able to work with ICBT anytime, anywhere and to a chosen 
extent is favourable but the responsibility placed on the patient in ICBT is 
considerable. Ease of use and smoothly functioning technology is crucial. 
Patients need different amounts of support from a psychotherapist. An 
individual treatment design seems to be preferred, and elements of ICBT could 
be included as a complement to face-to-face meetings. There is no evidence of 
ICBT or TAU being more advantageous than the other. This result is in line 
with the general practice idea that having a plethora of treatment options to 
choose between is a strength.  
Collaborative care with a care manager is an effective way of providing care 
for depression in Swedish primary care from the perspectives of cost-
effectiveness and PCC director and clinician experience. From a societal 
perspective, CCCM generates higher health benefits for the patient at lower 
costs compared to CAU. From a health care perspective, CCCM is cost-
effective already at a modest WTP per QALY threshold. Both PCC clinicians 
and directors are generally positive to implementing and working in CCCM. 
Important facilitators are support from colleagues and directors, cooperative 
skills and positive clinician attitudes. Barriers are high workload, shortage of 
staff and extensive requirements and demands from the health care 
organisation. Guidelines and education are important. These results are of high 
relevance for decision makers on a national level.  
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Future perspectives 
Our cost-effectiveness analysis of CCCM in PRIM-CARE was conducted at a 
six-month follow-up. Data from the twelve-month follow-up will be available 
and analysed from a cost-effectiveness perspective. Results on fidelity of the 
implementation as well as patient and GP experiences of CCCM will be 
published shortly.  
In the future, effectiveness studies including cost questionnaires could be used 
to gather even more accurate data on productivity loss from absenteeism, and 
to estimate presenteeism. The societal costs of reduced daily functioning (e.g. 
less availability to support children and relatives) could also be assessed. 
ICBT was perceived differently depending on personality. Further studies of 
ICBT for depression could benefit from analysing potential differences in 
effects, costs and experiences for different personality profiles or other 
differences between groups of individuals. Further studies on blending ICBT 
and other aspects of psychotherapeutic intervention for the most appropriate 
point of delivery in the depression episode according to the patient and the 
professional, would be valuable in this more person-centred model.  
Further studies should investigate ICBT delivered via other forms of 
technology, such as tablet computers and smart phones. Psychotherapist 
support in chats or internet-mediated video calls is another development that 
could provide better outcomes and should be further investigated in the 
primary care setting. 
Most important to keep in mind in future research is that study design and 
execution be based on the real world to create as much value as possible.  
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